WO2016085236A1 - Method and system for automatic determination of thyroid cancer - Google Patents

Method and system for automatic determination of thyroid cancer Download PDF

Info

Publication number
WO2016085236A1
WO2016085236A1 PCT/KR2015/012660 KR2015012660W WO2016085236A1 WO 2016085236 A1 WO2016085236 A1 WO 2016085236A1 KR 2015012660 W KR2015012660 W KR 2015012660W WO 2016085236 A1 WO2016085236 A1 WO 2016085236A1
Authority
WO
WIPO (PCT)
Prior art keywords
nodule
thyroid cancer
image
diameter
database
Prior art date
Application number
PCT/KR2015/012660
Other languages
French (fr)
Korean (ko)
Inventor
백정환
심우현
최영준
Original Assignee
재단법인 아산사회복지재단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 재단법인 아산사회복지재단 filed Critical 재단법인 아산사회복지재단
Publication of WO2016085236A1 publication Critical patent/WO2016085236A1/en

Links

Images

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08Detecting organic movements or changes, e.g. tumours, cysts, swellings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02Instruments for taking cell samples or for biopsy
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
    • G06Q50/10Services
    • G06Q50/22Social work or social welfare, e.g. community support activities or counselling services
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00ICT specially adapted for the handling or processing of medical images
    • G16H30/40ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00ICT specially adapted for the handling or processing of medical images
    • G16H30/20ICT specially adapted for the handling or processing of medical images for handling medical images, e.g. DICOM, HL7 or PACS

Definitions

  • the present invention relates to a method and system for discriminating thyroid cancer as a risk with high accuracy using ultrasound images and previous biopsy results.
  • the thyroid gland is one of the endocrine organs that secretes thyroid hormones. Diseases in which the thyroid abnormalities occur are largely two types, thyroid dysfunction that can be cured by drug treatment, etc., and nodules or nodules of the thyroid.
  • thyroid nodules In the case of thyroid nodules, about 95% are benign nodules, which are not normal cells but adenomas, clusters or blisters, which are not cancerous. About 5% is thyroid cancer, the slowest growing cancer among humans, but malignant in need of treatment.
  • Ultrasound diagnosis is most widely used for thyroid cancer diagnosis, and biopsy is used to improve accuracy.
  • the doctor recommends taking an ultrasound image, and the ultrasound implementer takes an ultrasound of the patient using the ultrasound machine 100.
  • the captured ultrasound image is acquired by the image extracting means 110, and the acquired ultrasound image is directly transmitted to the reader or when the PACS, i.e., a picture archiving and communication system, is constructed, the hospital database 200 Is uploaded to the PACS database 210 and delivered to the reader.
  • the readout person visually checks the transmitted image through the output unit 400 to determine whether thyroid cancer is present. Based on the experience and knowledge of the reader, nodules presumably cancers are found, and the shape, size, boundary, internal components, degree of calcification, and echo are determined visually. Based on the result of the decision, the clinician again estimates thyroid cancer based on experience, knowledge, and manual, and decides whether to perform biopsy or follow-up based on the malignant risk.
  • the read result determined as described above is directly transmitted to the attending physician or uploaded to the PACS database 210 of the hospital database 200.
  • an EMR system that is, an electronic medical record system, is uploaded and delivered to the EMR database 220.
  • the patient has a biopsy results are delivered directly to the attending physician, or computerized through the biopsy record input unit 225 is uploaded to the EMR database 220 is delivered.
  • the attending physician will examine the treatment method based on the results of the above tests, the results of the readings and the biopsy. Depending on the results of the biopsy, a retest may be performed.
  • This process has the following problems.
  • the image acquisition step and the readout step are dualized, which takes considerable time. Also, the interpretation of the image is very different depending on the subjective opinion of the reader. For example, looking at the deformed elongated oval nodule, some may be considered ovoids and some are irregular. In addition, since the combination of shapes, sizes, boundaries, internal components, degree of calcification, and echoes, which are the criteria for determination, varies widely, it is difficult to calculate the human reading alone by combining all of them.
  • thyroid cancer is most often a cancer that does not progress quickly. In other words, it is preferable to avoid surgery and avoid biopsies if it is not a clear diagnosis of cancer.
  • the reading result and treatment method are different for each of the physician or physician in charge so that unnecessary surgery or biopsy is performed. The disadvantage is that it can.
  • Korean Laid-Open Patent Publication No. 10-2014-0094760 discloses an apparatus for predicting whether malignant tumors exist in a subject using a medical image. Although it calculates the probability of being a malignant tumor, it is not accurate because the patient's medical records are not referenced, and it is difficult to apply when a new cancer discrimination method or criterion is presented because it is calculated based only on the degree of microcalcification. Because it is a method for discriminating all types of cancer, the specificity of thyroid cancer is not taken into account.
  • US patent application 2011-0295782 discloses a method for identifying the malignant risk of thyroid nodules.
  • lymph node size is extracted and used from an ultrasound image. The accuracy is low because only the node size is used and the patient's medical records are not referenced.
  • US Patent No. 8,366,619 discloses an apparatus for determining whether malignant nodules by checking the stiffness index of the nodules using ultrasonic elastomeric.
  • the prior art uses physical examination results that do not use images.
  • the present invention has been made to solve the above problems.
  • an embodiment of the present invention (a) the image extraction means 110 to extract the ultrasound image; (b) the image analyzing means 120 detecting a nodule in the extracted ultrasound image and calculating values of a plurality of factors of the nodule; (c) the risk calculating means (310) retrieving medical records from a database, and calculating the risk by a predetermined method using the values of the plurality of factors and the medical records of step (b); (d) determining, by the risk calculating means 310, whether the detected nodule is a nodule of a predetermined shape according to a guideline criterion when the calculated risk is greater than or equal to a predetermined criterion; (e) in the case of a nodule of a predetermined shape according to the guidelines, the diagnostic information calculating means 320 determining whether the diameter of the nodule is greater than 1 cm; (f) the diagnostic information calculating means 320 outputs a "tissue examination" through the output unit 400 when the diameter of the nodule
  • the diagnostic information calculating means 320 if the diameter of the nodule is greater than 2cm through the output unit 400 It is preferable to further include the step of outputting the "history examination", and outputting "overlook observation” through the output unit 400 when the diameter of the nodule is 2 cm or less.
  • the nodule of the predetermined shape is preferably an indeterminate nodule.
  • the diagnostic information calculating means 320 determines whether the diameter of the nodule is greater than 0.5cm; (f1) the diagnostic information calculating means 320 outputs a "tissue examination" through the output unit 400 when the diameter of the nodule is greater than 0.5 cm, and the output unit when the diameter of the nodule is 0.5 cm or less. It is preferable to further include the step of outputting "observation" through (400).
  • step (f) updating the medical record by inputting a biopsy result in the database; (h) extracting the second ultrasound image by the image extracting means (110); (i) the image analyzing means (120) detecting a nodule in the extracted second ultrasound image and recalculating a value of a plurality of factors of the nodule; (j) the risk calculating means 310 uses the values of the plurality of factors recalculated in the step (i) and the medical record updated in the step (g), by the predetermined method of the step (c).
  • the diagnostic information calculating means 320 calculates a risk; (k) If the calculated risk is greater than or equal to the predetermined criterion, the diagnostic information calculating means 320 outputs a "tissue examination" through the output unit 400, otherwise, through the output unit 400. Preferably, the method further includes outputting an "observation”.
  • the previous biopsy result (Previous Biopsy Result) of step (c) and the biopsy result input in step (g) are divided into the procedure method and the biopsy result, the biopsy result is a six-step diagnosis It is preferable that the result is recorded as a value according to the classification system (Bethesda System for Reporting Thyroid Cytopathology).
  • the plurality of factors include diameter, internal content, sponge appearance, shape, margin, echogenicity, and calcification. It is preferable.
  • the image analysis means 120 uses the image extracted in the step (a), calculates the diameter of the nodule, the internal components of the nodule (solid), almost solid (predominantly solid) ), Almost predominantly cystic, cystic (cystic), calculates the presence of the nodule on the spongy, and the shape of the nodule (ovoid / round), irregular (irregular), rectangular (taller than) compute the boundary of the nodule as either smooth, ill-defined, or spiculated, and echo the nodules.
  • the diagram is computed with any one of marked hypoechogenicity, hypoechogenicity, isoechogenicity, and hyperechogenicity, and the calcification of the nodule is microcalcified, rim calcification. It is preferable to operate with either macrocalcification.
  • the input unit 315 is preferably a step of inputting the values of the plurality of factors of the nodule detected in the extracted ultrasound image.
  • the image analysis means 120 includes a step of detecting a plurality of nodules in the extracted ultrasound image and setting the priority of the plurality of nodules based on their size. Do.
  • the image extraction means 110 for extracting the ultrasound image
  • Image analysis means (120) for detecting a nodule in the ultrasound image extracted by the image extraction means and calculating values of a plurality of factors of the nodule
  • Retrieve a medical record from a database calculate the risk by a predetermined method using the values of the plurality of factors and the medical record, and if the calculated risk is above a predetermined criterion, the detected nodule is based on guidelines.
  • a risk calculating means 310 for determining whether a nodule of a predetermined shape according to; Diagnostic information calculating means (320) for determining whether the diameter of the nodule is greater than 1 cm in the case of a nodule of a predetermined shape according to the guidelines; And an output unit 400 outputting "history examination” when the diameter of the nodule is greater than 1 cm, and outputting "transspective observation” when the diameter of the nodule is 1 cm or less.
  • the medical record provides an automatic thyroid cancer discrimination system including a previous biopsy result.
  • the database is preferably an electronic medical record (EMR) database 220 of the hospital database 200.
  • EMR electronic medical record
  • the hospital database 200 PACS (Picture Archiving and Communication System) is uploaded to the ultrasound image extracted from the image extraction means 100 and the value of a plurality of factors calculated by the image analysis means 120 It is preferable to further include a database 210.
  • PACS Picture Archiving and Communication System
  • a biopsy result may be further input to the EMR database 220.
  • the previous biopsy results (Previous Biopsy Result) and the biopsy results are divided into the procedure and the biopsy results, the biopsy results are values according to the six-stage diagnostic system (Bethesda System for Reporting Thyroid Cytopathology)
  • the thyroid cancer automatic detection system may further include a biopsy record input unit 225 capable of inputting the previous biopsy result and the biopsy result.
  • a guideline database 500 in which the guideline criteria are stored.
  • the guideline database 500 preferably extracts information about the guideline from a predetermined website and stores the guideline information based on the guideline.
  • the plurality of factors include diameter, internal components, sponge phase, shape, boundary, echo, and calcification, the automatic thyroid cancer determination system, input unit 315 that can input the value of the plurality of factors It is preferable to further include.
  • 1 is a view for explaining a thyroid cancer determination method according to the prior art.
  • FIG. 2 is a conceptual diagram illustrating a thyroid cancer determination system according to the present invention.
  • 3A and 3B are flowcharts illustrating a thyroid cancer determination method according to the present invention.
  • 4 and 5 illustrate screens output to an output unit when the thyroid cancer determination system and method according to the present invention are implemented.
  • system is to be understood as meaning an object that is the opposite of the method.
  • the size of the nodule means the distance on the largest straight line of the nodule. For example, if the crystal is elliptical, the long diameter, not the short diameter, is the size. In the following description, the term “diameter nodule” is used, but it should be understood as having the same meaning as "size of the nodule”.
  • the "operation unit” and “operation means” means information processing means for inputting information and performing arithmetic operation by a predetermined method or algorithm to derive a result.
  • An example may be a computer equipped with computing devices such as a CPU.
  • FIG. 1 is a diagrammatic representation of FIG. 1
  • the automatic thyroid cancer determination system includes an ultrasound machine 100, a hospital database 200, an operation unit 300, an output unit 400, and a guideline database 500.
  • the ultrasound machine 100 may be any ultrasound machine currently available, and may use any machine provided with an image extracting means 110 capable of extracting a photographed image and transferring it to a database or a calculation unit. However, it is characterized in that the image analysis means 120 is provided.
  • the image analyzing means 120 of the ultrasound machine 100 of the automatic thyroid cancer determination system performs the following functions.
  • all the plurality of nodules may be selected and selected from the extracted ultrasound image, and each priority may be determined according to a predetermined criterion.
  • the method of automatically selecting a nodule in the ultrasound image is a prior art and thus a detailed description thereof will be omitted.
  • Diameter As described above, refers to the size of the nodule, for example, the value is extracted in cm.
  • the image analyzing means 120 may calculate this based on the captured ultrasound image, and the criteria for distinguishing the four stages of classification, ie, "solidity” / "almost solidity” / "almost cystic” / "cystic" in advance It may be input, for example, 10%, 50%, 90% based on the ratio of the black points per pixel of the image may be distinguished. Since the image analysis method is a conventional technology, a detailed description thereof will be omitted.
  • ⁇ Spongiform appearance It is extracted with and without spongiform appearance.
  • the sea surface refers to a case in which a plurality of microcystic components are divided by a thin diaphragm, and the image analyzing means 120 may classify them based on a predetermined number of lines per unit pixel.
  • the image analyzing means 120 may determine the contour by using a contour determination technique, which is one of the conventional general techniques, and when it is included within a predetermined range of predetermined curvature, the image analysis means 120 may have a predetermined aspect ratio. If it is within the range, it is automatically classified into a rectangle if it is not rectangular, oval or rectangular.
  • Margin It is extracted by dividing into smooth, ill-defined, and spiculated.
  • the image analyzing means 120 automatically divides the shape of the boundary into the above three by using the contour determination technique.
  • Echoogenicity Extracted into distinctly marked hypoechogenicity, hypoechogenicity, isoechogenicity, and hyperechogenicity. "Earth low echo” is less echo of the nodule than the echo of the surrounding muscles, “low echo” is less echo of the nodule than the echo of the surrounding thyroid tissue, “back echo” is the echo of the surrounding thyroid tissue and nodules If it is the same, “koeko” means that the echo of the nodule is higher than the echo of the surrounding thyroid tissue.
  • the image analyzing means 120 can distinguish between the nodular portion and the non-nodular portion, and calculates the shade of each portion to compare the four pixels with the surrounding pixel region (ie, the surrounding thyroid tissue or the surrounding muscle). It is possible to automatically extract branched echoes.
  • ⁇ Calcification Extracted into three categories: microcalcification, rim calcification, and macrocalcification.
  • the image analyzing means 120 may automatically calculate the degree of calcification by calculating the number of white pixels per unit area and the density frequency of the white pixels in the unit area. .
  • the values of the plurality of factors may be automatically extracted by the image analyzing means 120 of the ultrasound machine 100, but in another embodiment, the risk calculating means may be provided through a separate input unit 315. It may also be entered directly into 310.
  • a screen input by the input unit 315 is shown in FIG. 4. In the first line, the previous biopsy result is disclosed, which is a part for inputting the already obtained biopsy result, which will be described later.
  • the hospital database 200 includes a PACS database 210 and an EMR database 220. You can also use an existing database.
  • the values of a plurality of factors automatically identified by the image analyzing means 120 are uploaded to the PACS database 210 of the hospital database 200 together with the ultrasound images. At this time, an identifier for identifying the patient is uploaded together.
  • the values and identifiers of the multiple factors uploaded to the PACS database 210 are linked with the EMR database 220 to retrieve the existing medical records of the patient, which are stored in advance, using the identifiers.
  • the existing medical record includes a previous biopsy result for patients with a history of biopsy.
  • the calculation unit 300 calculates the actual thyroid cancer risk and calculates what information of diagnostic information, for example, "observation” or "tissue examination” for a suitable medical treatment method is to be output.
  • the calculating unit 300 includes a risk calculating means 310 and a diagnostic information calculating means 320.
  • the risk calculator 310 retrieves a number of factors from the EMR database 220 in the ultrasound image and a previous biopsy result, which is an existing medical record of the patient.
  • Previous Biopsy Results include what was used as the procedure and the actual results (see Figure 5).
  • the procedure is classified into fine needle aspiration biopsy (FNAB) or core needle biopsy (CNB) and stored in the EMR database 220.
  • FNAB fine needle aspiration biopsy
  • CB core needle biopsy
  • the biopsy results are stored in an international six-step Bethesda System for Reporting Thyroid Cytopathology.
  • “1” means “non-diagnostic result", and the cell number is not enough to accurately diagnose.
  • the risk of thyroid cancer is 1 to 4%, but retesting is needed.
  • “2” is “benign nodule” and the risk of thyroid cancer is 0 to 3%.
  • "3" is an undetermined nodule divided into “AUS” and “FLUS”. Some cells are atypical, suspected of having thyroid cancer, or difficult to diagnose with clear benign nodules.
  • Thyroid cancer risk is 5 to 15%.
  • "4" is "follicular tumor (or suspected follicular tumor)”.
  • Thyroid cancer risk is 15 to 30%.
  • "5" is “suspect thyroid cancer”. Thyroid cancer risk is 60 to 75% and thyroid surgery is recommended.
  • “6” is diagnosed as “thyroid cancer” and the thyroid cancer risk is 97 to 99%.
  • the biopsy results are uploaded to the EMR database 220 of the hospital database 200 through a separate biopsy record input unit 225 provided in the EMR database 220.
  • the risk calculating means 310 automatically calculates the risk of thyroid cancer by combining the values of the plurality of factors thus collected and previous biopsy results. A specific calculation method is described in detail below.
  • the diagnostic information calculating means 320 calculates any one of "experimental observation” or "tissue examination” as diagnostic information based on the calculation result of the risk calculating means 310 and outputs it through the output unit 400. On the other hand, the diagnostic information calculation means 320 further utilizes one criterion, which is a general guideline criterion. Guidelines criteria may be extracted from the guidelines database 500.
  • the guideline database 500 is a website provided with a criterion for determining whether thyroid cancer is among Internet websites.
  • the guideline database 500 extracts information about a guideline from a predetermined website and stores the guideline as a guideline.
  • the predetermined website may be, for example, the Korean Society of Thyroid Imaging Medicine (http://thyroidimaging.kr/), and the system according to the present invention sets the index of "reference” among the data included in the website.
  • the "KSThR guideline” can be extracted automatically.
  • the extracted thyroid nodule (KSThR guideline) is, for example, the basis for the classification of benign nodules, indeterminate nodules, suspicious malignants, and normal nodules with nominal diameters of 2 cm, 1 cm, and 5 mm. In this case, since the diameter of the nodule is one of the values analyzed by the above-described image analyzing means 120, it is automatically determined where it corresponds.
  • the above-mentioned thyroid nodule (KSThR guideline) of the Korean Society of Thyroid Imaging Medicine is just one example, and as described above, it can be applied to any website that can extract the thyroid nodule by setting the "reference" as an index. to be.
  • the attending physician treats the patient and recommends taking an ultrasound image when the thyroid cancer is suspected, and the patient takes an ultrasound image in the ultrasound machine 100.
  • the captured ultrasound image is extracted by the image extracting means 110 (S100).
  • the ultrasound image may be an image in which a doctor directly takes an ultrasound image of a patient using a probe, or may be an image automatically scanned using a gel-pad probe.
  • the image analysis means 120 of the present invention detects the nodules in the extracted ultrasound image, determines the priority, and calculates values of a plurality of factors for each nodule (S200). Many of the factors computed here are seven: Diameter, Internal Content, Spongiform appearance, Shape, Margin, Echogenicity, and Calcification. Dog.
  • the value of the plurality of factors may be manually input by using a separate input unit 315.
  • the risk calculating unit 310 calculates the risk in a predetermined manner by combining the values of the plurality of factors (S300).
  • each factor may be weighted. For another example, if any one factor approaches 10, it may be calculated in a manner that increases the risk. As such, if seven factors are automatically or manually extracted, they may be combined in any way, and the scope of the present invention is to determine whether thyroid cancer is used using a plurality of factors, and calculates the value of the factor. Note that it is not a specific formula to.
  • Previous Biopsy Results are stored in a six-step diagnostic system (Bethesda System for Reporting Thyroid Cytopathology), as described above, to calculate each value, which can be added to the seven factors described above. have.
  • Such output is output along with the ultrasound image through the monitor provided in the ultrasound machine 100, through the monitor associated with the PACS or EMR in the hospital, or of course there is no limitation.
  • the guidelines database 500 it is preferable to apply the guidelines once again from the guidelines database 500 rather than unconditional biopsy.
  • the guideline is the above-mentioned thyroid nodule (KSThR guideline) of the Korean Society of Thyroid Imaging Medicine (S410)
  • the nodule (indeterminate) S410
  • the diameter is less than 1cm (S510)
  • a biopsy is not necessary. It can be diagnosed as follow-up observation. That is, "pass observation” is output through the output unit 400 (S600). Lowering from 2 cm to 1 cm is a higher risk and a stricter standard. If the diameter is more than 1 cm, since a biopsy is necessary, the "history examination” is output through the output unit 400 (S700).
  • the diameter is not 0.5cm or less if the indeterminate nodule (S520) does not require a biopsy and can be diagnosed as a follow-up observation. That is, "pass observation” is output through the output unit 400 (S600). The decrease from 1 cm to 0.5 cm reflects a higher risk because it is not an indeterminate nodule. If the diameter is more than 0.5cm, because a biopsy is necessary, the "history examination" is output through the output unit 400 (S700).
  • the result is stored in the EMR database 220 again (S810).
  • the form to be stored is as described above.
  • the second ultrasonic inspection is performed through the ultrasonic machine 100, and the corresponding ultrasonic image is extracted by the image extracting means as the second ultrasonic image (S820), and each value of the plurality of factors is determined by the image analyzing means. It is recalculated (S830). The method is as described above.
  • the risk calculating means 310 calculates the second risk once again by combining the values of the plurality of factors recomputed and the medical records updated by uploading the biopsy to the EMR database 220 in step S720 (S840). ). If the secondary risk is still 5% or more as a result of the calculation (S850), the output unit 400 outputs a "history examination” again (S860), and still outputs an "observation”.
  • This method has the following advantages.
  • the present invention can improve the universality and accuracy by presenting an objective criterion based on a total of seven or more factors.
  • the procedure is terminated at the step S400 based on the subjective viewpoint of the judgment.
  • the invention excludes the subjective point of view of judgment and utilizes previous biopsy results, guideline criteria, and more than two times of ultrasound image analysis results. Or cancer removal surgery is not recommended.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Primary Health Care (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Business, Economics & Management (AREA)
  • Tourism & Hospitality (AREA)
  • General Physics & Mathematics (AREA)
  • General Business, Economics & Management (AREA)
  • Marketing (AREA)
  • Child & Adolescent Psychology (AREA)
  • Theoretical Computer Science (AREA)
  • Economics (AREA)
  • Strategic Management (AREA)
  • Human Resources & Organizations (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Apparatus For Radiation Diagnosis (AREA)

Abstract

The present invention relates to a method and system for determining, as a degree of risk, the presence or absence of thyroid cancer with high accuracy by using ultrasound images and result values of previous biopsies. Values for a plurality of factors are automatically or manually input from an ultrasound image, and result values of previous biopsies are utilized to provide a result that is highly accurate and universal.

Description

갑상선암 자동 판별 방법 및 시스템Automated thyroid cancer determination method and system
본 발명은 초음파 이미지와 이전 조직검사결과 등을 이용하여 정확도 높게 갑상선암 여부를 위험도로서 판별하는 방법과 시스템에 관한 것이다.The present invention relates to a method and system for discriminating thyroid cancer as a risk with high accuracy using ultrasound images and previous biopsy results.
갑상선은 갑상선 호르몬을 분비하는 내분비기관 중 하나이다. 갑상선에 이상이 발생하는 질환은 크게 두 가지로서, 약물치료 등으로 치유가 가능한 갑상선 기능 이상과, 갑상선의 혹 또는 결절을 들 수 있다. The thyroid gland is one of the endocrine organs that secretes thyroid hormones. Diseases in which the thyroid abnormalities occur are largely two types, thyroid dysfunction that can be cured by drug treatment, etc., and nodules or nodules of the thyroid.
갑상선 결절의 경우, 약 95% 정도는 양성 혹으로서 정상세포는 아니지만 암이라 할 수 없는 선종, 세포 뭉침 내지 물집이다. 약 5% 정도는 갑상선암으로서, 사람에게 발생하는 암 중에서 가장 천천히 자라는 특징을 갖지만 악성인바 치료가 필요하다. In the case of thyroid nodules, about 95% are benign nodules, which are not normal cells but adenomas, clusters or blisters, which are not cancerous. About 5% is thyroid cancer, the slowest growing cancer among humans, but malignant in need of treatment.
갑상선암 판별을 위하여 초음파 기계를 이용한 진단이 가장 널리 사용되며, 정확도 향상을 위하여 조직검사가 활용된다.Ultrasound diagnosis is most widely used for thyroid cancer diagnosis, and biopsy is used to improve accuracy.
도 1을 참조하여, 종래의 일반적인 갑상선암 판별 방법을 설명한다.Referring to Figure 1, a conventional general thyroid cancer determination method will be described.
담당의가 환자를 진료하며 갑상선암이 의심되면 초음파 영상의 촬영을 권유하고, 초음파 시행의사는 초음파 기계(100)를 이용하여 환자의 초음파를 촬영한다. 촬영한 초음파 이미지는 이미지 추출수단(110)에 의하여 획득되며, 획득된 초음파 이미지가 판독의에게 직접 전달되거나, 또는 PACS, 즉 의료영상정보시스템(Picture Archiving and Communication System) 구축된 경우 병원 데이터베이스(200)의 PACS 데이터베이스(210)에 업로드되어 판독의에게 전달된다. If the attending physician treats the patient and suspects thyroid cancer, the doctor recommends taking an ultrasound image, and the ultrasound implementer takes an ultrasound of the patient using the ultrasound machine 100. The captured ultrasound image is acquired by the image extracting means 110, and the acquired ultrasound image is directly transmitted to the reader or when the PACS, i.e., a picture archiving and communication system, is constructed, the hospital database 200 Is uploaded to the PACS database 210 and delivered to the reader.
판독의는 전달된 이미지를 출력부(400)를 통하여 육안으로 확인하면서 갑상선암 여부를 판별한다. 주로, 판독의의 경험과 지식에 의거하여, 암이라 추측되는 결절을 발견하고, 그 모양, 크기, 경계, 내부성분, 석회화 정도, 에코 등을 육안으로 결정한다. 이렇게 결정된 결과에 따라 판독의는 다시 경험, 지식, 매뉴얼 등을 바탕으로 갑상선암 여부를 추정하고, 악성 위험도 등을 종합하여 조직검사를 할지 아니면 경과관찰을 할지 결정한다. 이와 같이 결정된 판독 결과는 직접 담당의에게 전달되거나 병원 데이터베이스(200)의 PACS 데이터베이스(210)에 업로드되어 전달된다. EMR 시스템, 즉 전자의무기록(Electronic Medical Record) 시스템이 구축된 경우 EMR 데이터베이스(220)에도 업로드되어 전달된다.The readout person visually checks the transmitted image through the output unit 400 to determine whether thyroid cancer is present. Based on the experience and knowledge of the reader, nodules presumably cancers are found, and the shape, size, boundary, internal components, degree of calcification, and echo are determined visually. Based on the result of the decision, the clinician again estimates thyroid cancer based on experience, knowledge, and manual, and decides whether to perform biopsy or follow-up based on the malignant risk. The read result determined as described above is directly transmitted to the attending physician or uploaded to the PACS database 210 of the hospital database 200. When an EMR system, that is, an electronic medical record system, is uploaded and delivered to the EMR database 220.
한편, 환자가 조직검사를 하면 그 결과가 직접 담당의에게 전달되거나, 또는 조직검사기록 입력부(225)를 통하여 전산 입력되어 EMR 데이터베이스(220)에 업로드되어 전달된다. 담당의는 이상의 검사 결과들, 즉 판독결과와 조직검사 결과를 토대로 치료 방법을 검사하게 된다. 조직검사 결과에 따라서는 재검사를 실시하는 경우도 있다. On the other hand, when the patient has a biopsy results are delivered directly to the attending physician, or computerized through the biopsy record input unit 225 is uploaded to the EMR database 220 is delivered. The attending physician will examine the treatment method based on the results of the above tests, the results of the readings and the biopsy. Depending on the results of the biopsy, a retest may be performed.
이와 같은 과정은 다음의 문제점이 있다.This process has the following problems.
먼저, 영상 획득 단계와 판독 단계가 이원화되어 있어서 시간이 상당히 소요된다. 또한, 판독의의 주관적인 의견에 따라 영상 해석이 매우 달라진다. 예를 들어, 변형된 길쭉한 타원의 결절을 보고, 어떤 이는 타원(ovoid)으로, 어떤 이는 비정형(irregular)으로 판단할 수 있다. 또한, 판단 기준인 모양, 크기, 경계, 내부성분, 석회화 정도, 에코의 조합이 매우 다양하기에 이들을 모두 조합하여 사람인 판독의 혼자 연산하기 어려운 작업이다. First, the image acquisition step and the readout step are dualized, which takes considerable time. Also, the interpretation of the image is very different depending on the subjective opinion of the reader. For example, looking at the deformed elongated oval nodule, some may be considered ovoids and some are irregular. In addition, since the combination of shapes, sizes, boundaries, internal components, degree of calcification, and echoes, which are the criteria for determination, varies widely, it is difficult to calculate the human reading alone by combining all of them.
가장 중요하게는, 갑상선암은 대부분 진행이 빠르지 않은 암이라는 점이다. 즉, 확실한 암 진단이 아니라면 수술을 피하고, 가급적 조직검사도 피하는 것이 바람직함에도, 전술한 방법들에 의할 경우 판독의나 담당의마다 판독결과, 치료방법 등이 모두 달라져서 불필요한 수술 내지 조직검사가 이루어질 수 있다는 점이 단점이다.Most importantly, thyroid cancer is most often a cancer that does not progress quickly. In other words, it is preferable to avoid surgery and avoid biopsies if it is not a clear diagnosis of cancer. However, according to the above-described methods, the reading result and treatment method are different for each of the physician or physician in charge so that unnecessary surgery or biopsy is performed. The disadvantage is that it can.
이와 관련한 특허문헌을 검토한다.Review the patent literature related to this.
한국공개특허 제10-2014-0094760호는 의료 영상을 이용하여 대상체에 악성 종양이 존재하는지 여부를 예측하는 장치를 개시한다. 자동화되어 악성 종양일 확률을 연산해주지만, 해당 환자의 진료기록 등이 참조되지 않아 정확도가 낮으며 오직 미세석회화 정도만을 토대로 연산하기에 새로운 암 판별 방법 내지 기준이 제시될 경우 이에 대한 적용이 어려우며, 모든 종류의 암을 판별하기 위한 방법이기에, 갑상선암의 특수성이 감안되지 않는다.Korean Laid-Open Patent Publication No. 10-2014-0094760 discloses an apparatus for predicting whether malignant tumors exist in a subject using a medical image. Although it calculates the probability of being a malignant tumor, it is not accurate because the patient's medical records are not referenced, and it is difficult to apply when a new cancer discrimination method or criterion is presented because it is calculated based only on the degree of microcalcification. Because it is a method for discriminating all types of cancer, the specificity of thyroid cancer is not taken into account.
미국특허출원 제2011-0295782호는 갑상선 결절의 악성 위험도를 확인하는 방법을 개시한다. 갑상선암의 특수성을 감안하여 초음파 이미지에서 림프 노드 크기를 추출하여 이용하는데, 단순히 노드 크기만을 이용하고 해당 환자의 진료기록 등이 참조되지 않아 정확도가 낮다. US patent application 2011-0295782 discloses a method for identifying the malignant risk of thyroid nodules. In consideration of the specificity of thyroid cancer, lymph node size is extracted and used from an ultrasound image. The accuracy is low because only the node size is used and the patient's medical records are not referenced.
미국등록특허 제8,366,619호는 초음파 엘라스토그라피를 사용하여 결절의 강성도(stiffness index)를 확인함으로써 악성 결절 여부를 판별하는 장치를 개시한다. 본 종래기술은 영상을 이용하지 않는 물리적 검사 결과를 이용한다. US Patent No. 8,366,619 discloses an apparatus for determining whether malignant nodules by checking the stiffness index of the nodules using ultrasonic elastomeric. The prior art uses physical examination results that do not use images.
이상을 종합해보면, 현재 사용되는 갑상선암 판별 방법은 시간이 다수 소요되고 판독의마다 다른 결과에 이를 수 있어서 정확도 내지 신뢰수준이 높지 않으며, 암 수술이나 조직검사를 자주 권유한다는 점이 단점이다. 일부 특허문헌들은 판독의마다 다른 결과에 이르지 않도록 보편적인 기준을 제시하기도 하나, 역시 정확도에 문제가 있으며 갑상선암의 특수성이 잘 반영되지 못하였다. Taken together, the current method of determining thyroid cancer takes a lot of time and can lead to different results depending on the readout, so the accuracy or level of confidence is not high, and cancer surgery or biopsy is often recommended. Some patent documents provide universal criteria to prevent different readings, but are also problematic in accuracy and do not reflect the specificity of thyroid cancer.
<종래기술><Private Technology>
한국공개특허 제10-2014-0094760호Korean Patent Publication No. 10-2014-0094760
미국특허출원 제2011-0295782호United States Patent Application No. 2011-0295782
미국등록특허 제8,366,619호US Patent No. 8,366,619
본 발명은 상기와 같은 과제를 해결하기 위하여 안출된 것이다.The present invention has been made to solve the above problems.
즉, 신속하고 정확하며 보편성있는 기준으로 갑상선암을 판별할 수 있는 시스템 및 방법을 제안하고자 한다. 또한, 다른 암이 아닌 갑상선암의 특수성을 반영하여 정확도를 더욱 상승시킬 수 있는 시스템 및 방법을 제안하고자 한다.In other words, we propose a system and method for determining thyroid cancer on a fast, accurate and universal basis. In addition, it is proposed a system and method that can further increase the accuracy by reflecting the specificity of thyroid cancer, not other cancers.
상기와 같은 과제를 해결하기 위하여 본 발명의 일 실시예는, (a) 이미지 추출수단(110)이 초음파 이미지를 추출하는 단계; (b) 이미지 분석수단(120)이 상기 추출된 초음파 이미지에서 결절을 감지하고 상기 결절의 다수의 팩터의 값을 연산하는 단계; (c) 위험도 연산수단(310)이 데이터베이스로부터 진료기록을 불러오고, 상기 (b) 단계의 다수의 팩터의 값과 상기 진료기록을 이용하여 미리 결정된 방법에 의해 위험도를 연산하는 단계; (d) 상기 위험도 연산수단(310)이, 상기 연산된 위험도가 미리 결정된 기준 이상인 경우, 상기 감지된 결절이 가이드라인 기준에 따른 미리 결정된 형상의 결절인지 여부를 판단하는 단계; (e) 상기 가이드라인 기준에 따른 미리 결정된 형상의 결절인 경우, 진단정보 연산수단(320)이 상기 결절의 지름이 1cm 초과인지 여부를 판단하는 단계; (f) 상기 진단정보 연산수단(320)이, 상기 결절의 지름이 1cm 초과인 경우 출력부(400)를 통하여 "조직검사"를 출력하고, 상기 결절의 지름이 1cm 이하인 경우 상기 출력부(400)를 통하여 "경과관찰"을 출력하는 단계를 포함하며, 상기 (c) 단계의 진료기록은 이전 조직검사결과(Previous Biopsy Result)를 포함하는, 갑상선암 자동 판별 방법을 제공한다. In order to solve the above problems, an embodiment of the present invention, (a) the image extraction means 110 to extract the ultrasound image; (b) the image analyzing means 120 detecting a nodule in the extracted ultrasound image and calculating values of a plurality of factors of the nodule; (c) the risk calculating means (310) retrieving medical records from a database, and calculating the risk by a predetermined method using the values of the plurality of factors and the medical records of step (b); (d) determining, by the risk calculating means 310, whether the detected nodule is a nodule of a predetermined shape according to a guideline criterion when the calculated risk is greater than or equal to a predetermined criterion; (e) in the case of a nodule of a predetermined shape according to the guidelines, the diagnostic information calculating means 320 determining whether the diameter of the nodule is greater than 1 cm; (f) the diagnostic information calculating means 320 outputs a "tissue examination" through the output unit 400 when the diameter of the nodule is greater than 1 cm, and outputs 400 when the diameter of the nodule is 1 cm or less. ) And outputting a "horizontal observation", wherein the medical records of step (c) include a previous biopsy result, which provides an automatic thyroid cancer determination method.
또한, 상기 (d) 단계 이후, (d1) 상기 연산된 위험도가 상기 미리 결정된 기준 미만인 경우, 상기 진단정보 연산수단(320)이, 상기 결절의 지름이 2cm 초과인 경우 출력부(400)를 통하여 "조직검사"를 출력하고, 상기 결절의 지름이 2cm 이하인 경우 상기 출력부(400)를 통하여 "경과관찰"을 출력하는 단계를 더 포함하는 것이 바람직하다.Further, after the step (d), (d1) when the calculated risk is less than the predetermined criterion, the diagnostic information calculating means 320, if the diameter of the nodule is greater than 2cm through the output unit 400 It is preferable to further include the step of outputting the "history examination", and outputting "overlook observation" through the output unit 400 when the diameter of the nodule is 2 cm or less.
또한, 상기 (d) 단계에서, 상기 미리 결정된 형상의 결절은 불확정결절인것이 바람직하다.Also, in the step (d), the nodule of the predetermined shape is preferably an indeterminate nodule.
또한, 상기 (d) 단계 이후, (e1) 상기 가이드라인 기준에 따른 제 1 결절이 아닌 경우, 진단정보 연산수단(320)이 상기 결절의 지름이 0.5cm 초과인지 여부를 판단하는 단계; (f1) 상기 진단정보 연산수단(320)이, 상기 결절의 지름이 0.5cm 초과인 경우 출력부(400)를 통하여 "조직검사"를 출력하고, 상기 결절의 지름이 0.5cm 이하인 경우 상기 출력부(400)를 통하여 "경과관찰"을 출력하는 단계를 더 포함하는 것이 바람직하다.In addition, after the step (d), (e1) if it is not the first nodule according to the guidelines, the diagnostic information calculating means 320 determines whether the diameter of the nodule is greater than 0.5cm; (f1) the diagnostic information calculating means 320 outputs a "tissue examination" through the output unit 400 when the diameter of the nodule is greater than 0.5 cm, and the output unit when the diameter of the nodule is 0.5 cm or less. It is preferable to further include the step of outputting "observation" through (400).
또한, 상기 (f) 단계 이후, (g) 상기 데이터베이스에 조직검사 결과가 입력되어 진료기록이 갱신되는 단계; (h) 상기 이미지 추출수단(110)이 2차 초음파 이미지를 추출하는 단계; (i) 상기 이미지 분석수단(120)이 상기 추출된 2차 초음파 이미지에서 결절을 감지하고 상기 결절의 다수의 팩터의 값을 재연산하는 단계; (j) 상기 위험도 연산수단(310)이 상기 (i) 단계에서 재연산된 다수의 팩터의 값과 상기 (g) 단계에서 갱신된 진료기록을 이용하여 상기 (c) 단계의 미리 결정된 방법에 의해 위험도를 연산하는 단계; (k) 상기 연산된 위험도가 상기 미리 결정된 기준 이상인 경우 상기 진단정보 연산수단(320)은 상기 출력부(400)를 통하여 "조직검사"를 출력하고, 그렇지 않은 경우 상기 출력부(400)를 통하여 "경과관찰"을 출력하는 단계를 더 포함하는 것이 바람직하다.In addition, after the step (f), (g) updating the medical record by inputting a biopsy result in the database; (h) extracting the second ultrasound image by the image extracting means (110); (i) the image analyzing means (120) detecting a nodule in the extracted second ultrasound image and recalculating a value of a plurality of factors of the nodule; (j) the risk calculating means 310 uses the values of the plurality of factors recalculated in the step (i) and the medical record updated in the step (g), by the predetermined method of the step (c). Calculating a risk; (k) If the calculated risk is greater than or equal to the predetermined criterion, the diagnostic information calculating means 320 outputs a "tissue examination" through the output unit 400, otherwise, through the output unit 400. Preferably, the method further includes outputting an "observation".
또한, 상기 (c) 단계의 이전 조직검사결과(Previous Biopsy Result)와 상기 (g) 단계에서 입력되는 조직검사 결과는, 시술방법과 조직검사 결과로 구분된 것이며, 상기 조직검사 결과는 6단계 진단분류법(Bethesda System for Reporting Thyroid Cytopathology)에 의한 값으로 기록된 결과인 것이 바람직하다.In addition, the previous biopsy result (Previous Biopsy Result) of step (c) and the biopsy result input in step (g) are divided into the procedure method and the biopsy result, the biopsy result is a six-step diagnosis It is preferable that the result is recorded as a value according to the classification system (Bethesda System for Reporting Thyroid Cytopathology).
또한, 상기 다수의 팩터는, 지름(Diameter), 내부성분(Internal Content), 해면상(Spongiform appearance), 형상(Shape), 경계(Margin), 에코도(Echogenicity), 및 석회화(Calcification)를 포함하는 것이 바람직하다.In addition, the plurality of factors include diameter, internal content, sponge appearance, shape, margin, echogenicity, and calcification. It is preferable.
또한, 상기 이미지 분석수단(120)은, 상기 (a) 단계에서 추출된 이미지를 이용하여, 상기 결절의 지름을 연산하고, 상기 결절의 내부성분을 고형성(solid), 거의 고형성(predominantly solid), 거의 낭성(predominantly cystic), 낭성(cystic) 중 어느 하나로 연산하고, 상기 결절의 해면상의 유무를 연산하고, 상기 결절의 형상을 타원형(ovoid/round), 비정형(irregular), 장방형(taller than wide, 앞뒤가 긴 모양)의 세 가지 중 어느 하나로 연산하고, 상기 결절의 경계를 부드러운 경계(smooth), 불규칙 경계(ill-defined), 침상경계(spiculated) 중 어느 하나로 연산하고, 상기 결절의 에코도를 분명한 저에코(marked hypoechogenicity), 저에코(hypoechogenicity), 등에코(isoechogenicity), 고에코(hyperechogenicity) 중 어느 하나로 연산하고, 상기 결절의 석회화를 미세석회화(microcalcification), 주변부석회화(rim calcification), 거대석회화(macrocalcification) 중 어느 하나로 연산하는 것이 바람직하다.In addition, the image analysis means 120, using the image extracted in the step (a), calculates the diameter of the nodule, the internal components of the nodule (solid), almost solid (predominantly solid) ), Almost predominantly cystic, cystic (cystic), calculates the presence of the nodule on the spongy, and the shape of the nodule (ovoid / round), irregular (irregular), rectangular (taller than) compute the boundary of the nodule as either smooth, ill-defined, or spiculated, and echo the nodules. The diagram is computed with any one of marked hypoechogenicity, hypoechogenicity, isoechogenicity, and hyperechogenicity, and the calcification of the nodule is microcalcified, rim calcification. It is preferable to operate with either macrocalcification.
또한, 상기 (b) 단계는, 입력부(315)가 상기 추출된 초음파 이미지에서 감지된 상기 결절의 다수의 팩터의 값을 입력하는 단계인 것이 바람직하다.In addition, the step (b), the input unit 315 is preferably a step of inputting the values of the plurality of factors of the nodule detected in the extracted ultrasound image.
또한, 상기 (b) 단계는, 상기 이미지 분석수단(120)은 상기 추출된 초음파 이미지에서 다수의 결절을 감지하고 상기 다수의 결절을 그 크기를 기준으로 우선순위를 설정하는 단계를 포함하는 것이 바람직하다.In addition, the step (b), the image analysis means 120 includes a step of detecting a plurality of nodules in the extracted ultrasound image and setting the priority of the plurality of nodules based on their size. Do.
상기와 같은 과제를 해결하기 위하여 본 발명의 다른 실시예는, 초음파 이미지를 추출하는 이미지 추출수단(110); 상기 이미지 추출수단에서 추출된 초음파 이미지에서 결절을 감지하고 상기 결절의 다수의 팩터의 값을 연산하는 이미지 분석수단(120); 데이터베이스로부터 진료기록을 불러오고, 상기 다수의 팩터의 값과 상기 진료기록을 이용하여 미리 결정된 방법에 의해 위험도를 연산하며, 상기 연산된 위험도가 미리 결정된 기준 이상인 경우, 상기 감지된 결절이 가이드라인 기준에 따른 미리 결정된 형상의 결절인지 여부를 판단하는, 위험도 연산수단(310); 상기 가이드라인 기준에 따른 미리 결정된 형상의 결절인 경우 상기 결절의 지름이 1cm 초과인지 여부를 판단하는 진단정보 연산수단(320); 및 상기 진단정보 연산수단(320)의 판단 결과, 상기 결절의 지름이 1cm 초과인 경우 "조직검사"가 출력되고 상기 결절의 지름이 1cm 이하인 경우 "경과관찰"을 출력되는 출력부(400)를 포함하며, 상기 진료기록은 이전 조직검사결과(Previous Biopsy Result)를 포함하는, 갑상선암 자동 판별 시스템을 제공한다.Another embodiment of the present invention to solve the above problems, the image extraction means 110 for extracting the ultrasound image; Image analysis means (120) for detecting a nodule in the ultrasound image extracted by the image extraction means and calculating values of a plurality of factors of the nodule; Retrieve a medical record from a database, calculate the risk by a predetermined method using the values of the plurality of factors and the medical record, and if the calculated risk is above a predetermined criterion, the detected nodule is based on guidelines. A risk calculating means 310 for determining whether a nodule of a predetermined shape according to; Diagnostic information calculating means (320) for determining whether the diameter of the nodule is greater than 1 cm in the case of a nodule of a predetermined shape according to the guidelines; And an output unit 400 outputting "history examination" when the diameter of the nodule is greater than 1 cm, and outputting "transspective observation" when the diameter of the nodule is 1 cm or less. The medical record provides an automatic thyroid cancer discrimination system including a previous biopsy result.
또한, 상기 데이터베이스는 병원 데이터베이스(200)의 EMR(Electronic Medical Record) 데이터베이스(220)인 것이 바람직하다.In addition, the database is preferably an electronic medical record (EMR) database 220 of the hospital database 200.
또한, 상기 병원 데이터베이스(200)는, 상기 이미지 추출수단(100)에서 추출된 초음파 이미지와, 상기 이미지 분석수단(120)에서 연산된 다수의 팩터의 값이 업로드되는 PACS(Picture Archiving and Communication System) 데이터베이스(210)를 더 포함하는 것이 바람직하다.In addition, the hospital database 200, PACS (Picture Archiving and Communication System) is uploaded to the ultrasound image extracted from the image extraction means 100 and the value of a plurality of factors calculated by the image analysis means 120 It is preferable to further include a database 210.
또한, 상기 EMR 데이터베이스(220)에는 조직검사 결과가 더 입력될 수 있는 것이 바람직하다.In addition, it is preferable that a biopsy result may be further input to the EMR database 220.
또한, 상기 이전 조직검사결과(Previous Biopsy Result)와 상기 조직검사 결과는, 시술방법과 조직검사 결과로 구분된 것이며, 상기 조직검사 결과는 6단계 진단분류법(Bethesda System for Reporting Thyroid Cytopathology)에 의한 값으로 기록된 결과이며, 상기 갑상선암 자동 판별 시스템은, 상기 이전 조직검사결과(Previous Biopsy Result)와 상기 조직검사 결과를 입력할 수 있는 조직검사기록 입력부(225)를 더 포함하는 것이 바람직하다.In addition, the previous biopsy results (Previous Biopsy Result) and the biopsy results are divided into the procedure and the biopsy results, the biopsy results are values according to the six-stage diagnostic system (Bethesda System for Reporting Thyroid Cytopathology) The thyroid cancer automatic detection system may further include a biopsy record input unit 225 capable of inputting the previous biopsy result and the biopsy result.
또한, 상기 가이드라인 기준이 저장되는 가이드라인 데이터베이스(500)를 더 포함하는 것이 바람직하다.In addition, it is preferable to further include a guideline database 500 in which the guideline criteria are stored.
또한, 상기 가이드라인 데이터베이스(500)는, 미리 결정된 웹사이트에서 미리 결정된 방법에 따라 가이드라인에 대한 정보를 추출하여 상기 가이드라인 기준으로 저장한 것이 바람직하다.In addition, the guideline database 500 preferably extracts information about the guideline from a predetermined website and stores the guideline information based on the guideline.
또한, 상기 다수의 팩터는 지름, 내부성분, 해면상, 형상, 경계, 에코도, 및 석회화를 포함하며, 상기 갑상선암 자동 판별 시스템은, 상기 다수의 팩터의 값을 입력할 수 있는 입력부(315)를 더 포함하는 것이 바람직하다.In addition, the plurality of factors include diameter, internal components, sponge phase, shape, boundary, echo, and calcification, the automatic thyroid cancer determination system, input unit 315 that can input the value of the plurality of factors It is preferable to further include.
본 발명에 의하여, 신속하고 정확하며 병원이나 판독의/담당의마다 동일하거나 유사한 진단 결과를 제시할 수 있다.With the present invention, it is possible to present the same or similar diagnostic results quickly and accurately and for every hospital or reading / doctor.
또한, 갑상선암의 특수성이 십분 반영되어 정확도가 더욱 향상된다.In addition, the specificity of thyroid cancer is reflected in 10 minutes, further improving the accuracy.
또한, 환자의 종래 진료기록들이 점수화되어 반영되기에 환자의 개별적 특성도 고려되어 정확도가 더욱 향상된다.In addition, since the patient's conventional medical records are scored and reflected, the individual characteristics of the patient are also taken into consideration to further improve accuracy.
또한, 학회 등에서 가이드라인 기준이 달라지는 경우에도 실시간으로 본 시스템에 반영될 수 있어서 기준이 어떻게 바뀌더라도 가장 최근의 진료 경향 및 진단 경향이 그대로 반영될 수 있다.In addition, even if the guidelines change in the society, etc. can be reflected in the present system in real time, even if the standard changes, the most recent treatment tendency and diagnosis tendency can be reflected as it is.
또한, 현재 사용되고 있는 PACS 및 EMR과의 연동이 가능하여, 데이터베이스 관리가 용이하여 빅데이터의 구축이 가능하고, 구축된 데이터를 토대로 회귀분석이 이루어지고, 분석된 결과가 다시 기준으로 반영될 수 있어서, 데이터가 누적될수록 그 정확도가 더욱 향상될 수 있다. In addition, it is possible to link with the currently used PACS and EMR, easy to manage the database, it is possible to build big data, regression analysis is performed based on the built data, and the analyzed results can be reflected as a standard again As data accumulates, the accuracy can be further improved.
환자 입장에서는 암 확률이 매우 높지 않음에도 수행할 수 있었던 불필요한 조직검사나 암 제거 수술을 하지 않아도 되기에, 진료비를 절감하고 삶의 불편함을 최소화할 수 있으며, 궁극적으로는 국민 생활 증진에도 긍정적인 영향을 줄 수 있다.Since patients do not have a very high chance of cancer, they do not have to carry out unnecessary biopsies or surgery to remove cancer, thereby reducing medical expenses and minimizing their discomfort. May affect
도 1은 종래 기술에 따른 갑상선암 판별 방법을 설명하기 위한 도면이다.1 is a view for explaining a thyroid cancer determination method according to the prior art.
도 2는 본 발명에 따른 갑상선암 판별 시스템을 설명하기 위한 개념도이다.2 is a conceptual diagram illustrating a thyroid cancer determination system according to the present invention.
도 3a 및 도 3b는 본 발명에 따른 갑상선암 판별 방법을 설명하기 위한 순서도이다. 3A and 3B are flowcharts illustrating a thyroid cancer determination method according to the present invention.
도 4 및 도 5는 본 발명에 따른 갑상선암 판별 시스템 및 방법의 구현시 출력부로 출력되는 화면을 도시한다.4 and 5 illustrate screens output to an output unit when the thyroid cancer determination system and method according to the present invention are implemented.
여기에서 "시스템"은 방법의 반대인 물건을 의미하는 것으로 이해되어야 한다. Here "system" is to be understood as meaning an object that is the opposite of the method.
여기에서, "결절의 크기"는 결절의 가장 큰 직선 상의 거리를 의미한다. 예를 들어, 결정이 타원형인 경우 단직경이 아닌 장직경이 그 크기가 된다. 이하에서는 설명을 위하여 "결절의 지름"이라는 용어를 사용하나, "결절의 크기"와 동일한 의미로 이해되어야 할 것이다.Here, "the size of the nodule" means the distance on the largest straight line of the nodule. For example, if the crystal is elliptical, the long diameter, not the short diameter, is the size. In the following description, the term "diameter nodule" is used, but it should be understood as having the same meaning as "size of the nodule".
여기에서, "연산부", "연산수단"은 정보가 입력되어 미리 설정된 방법 및 알고리즘 등에 의하여 연산을 수행하여 결과를 도출하는 정보처리수단을 의미한다. CPU 등의 연산장치들이 구비된 컴퓨터가 일례일 수 있다.Here, the "operation unit" and "operation means" means information processing means for inputting information and performing arithmetic operation by a predetermined method or algorithm to derive a result. An example may be a computer equipped with computing devices such as a CPU.
갑상선암 자동 판별 시스템의 설명Description of Automatic Thyroid Cancer Screening System
이하, 도 2, 4, 5를 참조하여 본 발명에 대하여 상세히 설명한다. Hereinafter, the present invention will be described in detail with reference to FIGS. 2, 4 and 5. FIG.
본 발명에 따른 갑상선암 자동 판별 시스템은, 초음파 기계(100), 병원 데이터베이스(200), 연산부(300), 출력부(400), 및 가이드라인 데이터베이스(500)를 포함한다. The automatic thyroid cancer determination system according to the present invention includes an ultrasound machine 100, a hospital database 200, an operation unit 300, an output unit 400, and a guideline database 500.
초음파 기계(100)는 현재 입수 가능한 어떠한 초음파 기계도 가능하며, 촬영한 이미지를 추출하여 데이터베이스 내지 연산부에 전달할 수 있는 이미지 추출수단(110)이 구비된 어떠한 기계를 사용하여도 무방하다. 다만, 이미지 분석수단(120)이 구비된 것이 특징이다. The ultrasound machine 100 may be any ultrasound machine currently available, and may use any machine provided with an image extracting means 110 capable of extracting a photographed image and transferring it to a database or a calculation unit. However, it is characterized in that the image analysis means 120 is provided.
본 발명에 따른 갑상선암 자동 판별 시스템의 초음파 기계(100)의 이미지 분석수단(120)은 아래의 기능을 수행한다. The image analyzing means 120 of the ultrasound machine 100 of the automatic thyroid cancer determination system according to the present invention performs the following functions.
첫째, 추출된 초음파 이미지에서 다수의 결절을 모두 구분하여 선택할 수 있으며, 미리 결정된 기준에 따라 각각의 우선순위를 결정한다. 초음파 이미지에서 결절이 자동으로 선택되는 방법은 종래기술인바 상세한 설명은 생략한다. First, all the plurality of nodules may be selected and selected from the extracted ultrasound image, and each priority may be determined according to a predetermined criterion. The method of automatically selecting a nodule in the ultrasound image is a prior art and thus a detailed description thereof will be omitted.
둘째, 선택된 결절들 각각에서 원하는 정보를 추출한다. 즉, 미리 결정된 팩터(factor)들의 값이 자동으로 추출되어야 한다. 추출되는 다수의 팩터는 다음과 같다.Second, extract the desired information from each of the selected nodules. In other words, the values of the predetermined factors should be extracted automatically. A number of factors to be extracted are as follows.
■ 지름(Diameter): 전술한 바와 같이, 결절의 크기를 의미하며, 예를 들어 cm 단위로 값이 추출된다. Diameter: As described above, refers to the size of the nodule, for example, the value is extracted in cm.
■ 내부성분(Internal Content): 고형성(solid), 거의 고형성(predominantly solid), 거의 낭성(predominantly cystic), 낭성(cystic)의 네 단계로 구분된 값이 추출된다. 이미지 분석수단(120)은 촬영된 초음파 이미지를 토대로 이를 계산할 수 있으며, 네 단계들의 구분 기준, 즉 "고형성" / "거의 고형성" / "거의 낭성" / "낭성"을 구분하는 기준이 미리 입력될 수 있는데, 예를 들어 이미지의 픽셀당 흑색 포인트의 비율을 기준으로 10%, 50%, 90%로서 이들을 구분할 수도 있다. 이러한 이미지 분석 방법은 종래 기술인바 상세한 설명은 생략한다.Internal Content: Four levels of values are extracted: solid, nearly solid, almost cystic, and cystic. The image analyzing means 120 may calculate this based on the captured ultrasound image, and the criteria for distinguishing the four stages of classification, ie, "solidity" / "almost solidity" / "almost cystic" / "cystic" in advance It may be input, for example, 10%, 50%, 90% based on the ratio of the black points per pixel of the image may be distinguished. Since the image analysis method is a conventional technology, a detailed description thereof will be omitted.
■ 해면상(Spongiform appearance): 있음과 없음으로 구분되어 추출된다. 해면상은 다수의 미세낭성 성분이 얇은 격막에 의해 나뉘어 보이는 경우를 의미하며, 이미지 분석수단(120)은 미리 결정된 단위 픽셀 당 연결된 선의 개수를 기준으로 이들을 구분할 수 있다. ■ Spongiform appearance: It is extracted with and without spongiform appearance. The sea surface refers to a case in which a plurality of microcystic components are divided by a thin diaphragm, and the image analyzing means 120 may classify them based on a predetermined number of lines per unit pixel.
■ 형상(Shape): 타원형(ovoid/round), 비정형(irregular), 장방형(taller than wide, 앞뒤가 긴 모양)의 세 가지로 구분되어 추출된다. 이미지 분석수단(120)은 종래 일반적인 기술 중 하나인 윤곽확정기술을 이용하여 해당 윤곽을 결정할 수 있으며, 이를 통하여 미리 결정된 소정의 곡률의 범위 내에 포함되는 경우 타원형, 타원형은 아니지만 미리 결정된 가로세로비율의 범위 내에 포함되는 경우 장방형, 타원형과 장방형 모두 아닌 경우 비정형으로 자동으로 구분한다.■ Shape: It is extracted into three types: oval / round, irregular, and rectangular (wideler than wide). The image analyzing means 120 may determine the contour by using a contour determination technique, which is one of the conventional general techniques, and when it is included within a predetermined range of predetermined curvature, the image analysis means 120 may have a predetermined aspect ratio. If it is within the range, it is automatically classified into a rectangle if it is not rectangular, oval or rectangular.
■ 경계(Margin): 부드러운 경계(smooth), 불규칙 경계(ill-defined), 침상경계(spiculated)로 구분되어 추출된다. 이미지 분석수단(120)은 윤곽확정기술을 이용함으로써 해당 경계의 형상을 위의 세 가지로 자동으로 구분한다.Margin: It is extracted by dividing into smooth, ill-defined, and spiculated. The image analyzing means 120 automatically divides the shape of the boundary into the above three by using the contour determination technique.
■ 에코도(Echogenicity): 분명한 저에코(marked hypoechogenicity), 저에코(hypoechogenicity), 등에코(isoechogenicity), 고에코(hyperechogenicity)로 구분되어 추출된다. "분명한 저에코"는 주변 근육의 에코보다 결절의 에코가 낮은 경우, "저에코"는 주변 갑상선 조직의 에코보다 결절의 에코가 낮은 경우, "등에코"는 주변 갑상선 조직의 에코와 결절의 에코가 동일한 경우, "고에코"는 주변 갑상선 조직의 에코보다 결절의 에코가 높은 경우를 의미한다. 앞서 언급한 바와 같이, 이미지 분석수단(120)은 결절 부분과 비결절 부분을 구분할 수 있으며, 각 부분들의 음영을 연산하여 주변 픽셀 영역(즉, 주변 갑상선 조직 또는 주변 근육)과 비교함으로써 위의 네 가지로 구분된 에코도를 자동으로 추출할 수 있다.■ Echoogenicity: Extracted into distinctly marked hypoechogenicity, hypoechogenicity, isoechogenicity, and hyperechogenicity. "Earth low echo" is less echo of the nodule than the echo of the surrounding muscles, "low echo" is less echo of the nodule than the echo of the surrounding thyroid tissue, "back echo" is the echo of the surrounding thyroid tissue and nodules If it is the same, "koeko" means that the echo of the nodule is higher than the echo of the surrounding thyroid tissue. As mentioned above, the image analyzing means 120 can distinguish between the nodular portion and the non-nodular portion, and calculates the shade of each portion to compare the four pixels with the surrounding pixel region (ie, the surrounding thyroid tissue or the surrounding muscle). It is possible to automatically extract branched echoes.
■ 석회화(Calcification): 미세석회화(microcalcification), 주변부석회화(rim calcification), 거대석회화(macrocalcification)로 구분되어 추출된다. 석회화가 진행되면 초음파 이미지에서 백색 점과 같은 표지가 나타나는데, 이미지 분석수단(120)은 단위 면적 당 백색 픽셀의 개수, 단위 면적 내 백색 픽셀들의 치밀성 빈도를 연산함으로써 석회화 정도를 자동으로 연산할 수 있다. ■ Calcification: Extracted into three categories: microcalcification, rim calcification, and macrocalcification. When calcification proceeds, a mark such as a white dot appears in the ultrasound image. The image analyzing means 120 may automatically calculate the degree of calcification by calculating the number of white pixels per unit area and the density frequency of the white pixels in the unit area. .
한편, 일 실시예에서는 이와 같은 다수의 팩터의 값이 초음파 기계(100)의 이미지 분석수단(120)에서 자동으로 추출될 수도 있으나, 다른 실시예에서는 별도의 입력부(315)를 통하여 위험도 연산수단(310)에 수동으로 직접 입력될 수도 있다. 입력부(315)에 의하여 입력되는 화면의 하나의 예시가 도 4에 도시된다. 가장 첫 줄에는 이전 조직검사결과(Previous Biopsy Result)가 개시되어 있는데, 이는 이미 이루어진 조직검사 결과를 입력하는 부분인데 관련 부분은 후술하도록 한다. Meanwhile, in one embodiment, the values of the plurality of factors may be automatically extracted by the image analyzing means 120 of the ultrasound machine 100, but in another embodiment, the risk calculating means may be provided through a separate input unit 315. It may also be entered directly into 310. One example of a screen input by the input unit 315 is shown in FIG. 4. In the first line, the previous biopsy result is disclosed, which is a part for inputting the already obtained biopsy result, which will be described later.
병원 데이터베이스(200)는, PACS 데이터베이스(210)와 EMR 데이터베이스(220)를 포함한다. 기존의 데이터베이스를 사용하여도 무방하다. The hospital database 200 includes a PACS database 210 and an EMR database 220. You can also use an existing database.
이미지 분석수단(120)에서 자동으로 확인된 다수의 팩터의 값들은 초음파 이미지와 함께 병원 데이터베이스(200)의 PACS 데이터베이스(210)에 업로드된다. 이때 해당 환자를 식별할 수 있는 식별자(identifier)가 함께 업로드된다. The values of a plurality of factors automatically identified by the image analyzing means 120 are uploaded to the PACS database 210 of the hospital database 200 together with the ultrasound images. At this time, an identifier for identifying the patient is uploaded together.
PACS 데이터베이스(210)에 업로드된 다수의 팩터의 값과 식별자는 EMR 데이터베이스(220)와 연계되어, 식별자를 활용하여 미리 저장되어 있는 해당 환자의 기존 진료기록을 불러옴과 동시에 다수의 팩터의 값이 저장된다. 여기에서, 기존 진료기록은 조직검사 이력이 있는 환자의 경우 이전 조직검사결과(Previous Biopsy Result)를 포함한다. The values and identifiers of the multiple factors uploaded to the PACS database 210 are linked with the EMR database 220 to retrieve the existing medical records of the patient, which are stored in advance, using the identifiers. Stored. Here, the existing medical record includes a previous biopsy result for patients with a history of biopsy.
연산부(300)는 실재 갑상선암 위험도를 연산하고 적합한 진료방법에 대한 진단정보, 예를 들어 "경과관찰" 또는 "조직검사" 중 어떠한 정보를 출력할지 연산한다. 연산부(300)는 위험도 연산수단(310)과 진단정보 연산수단(320)을 포함한다.The calculation unit 300 calculates the actual thyroid cancer risk and calculates what information of diagnostic information, for example, "observation" or "tissue examination" for a suitable medical treatment method is to be output. The calculating unit 300 includes a risk calculating means 310 and a diagnostic information calculating means 320.
위험도 연산수단(310)은, EMR 데이터베이스(220)로부터 초음파 이미지에서 다수의 팩터의 값과 해당 환자의 기존 진료기록인 이전 조직검사결과(Previous Biopsy Result)를 불러온다. The risk calculator 310 retrieves a number of factors from the EMR database 220 in the ultrasound image and a previous biopsy result, which is an existing medical record of the patient.
이전 조직검사결과(Previous Biopsy Result)는, 시술 방법으로 무엇을 사용하였는지와 실재 시술 결과가 포함된다(도 5 참조)Previous Biopsy Results include what was used as the procedure and the actual results (see Figure 5).
시술방법은, 세침흡인생검(FNAB; fine needle aspiration biopsy)인지, 중심침생검(CNB; core needle biopsy)인지 여부로 구분되어 EMR 데이터베이스(220)에 저장되어 있다. The procedure is classified into fine needle aspiration biopsy (FNAB) or core needle biopsy (CNB) and stored in the EMR database 220.
조직검사 결과는, 갑상선암의 국제적인 6단계 진단분류법(Bethesda System for Reporting Thyroid Cytopathology)으로 저장된다. The biopsy results are stored in an international six-step Bethesda System for Reporting Thyroid Cytopathology.
"1"은 "비진단적 결과"를 의미하며, 세포수가 충분치 않아 정확한 진단이 불가능한 경우이다. 일반적으로 갑상선암 위험도가 1 ~ 4%이나 재검사가 필요한 경우이다. "2"는 "양성결절"로서, 갑상선암 위험도가 0 ~ 3%이다. "3"은 미확정 결절로서 "AUS"과 "FLUS"로 구분된다. 일부 세포가 비정형으로 갑상선암이 의심되거나 분명한 양성 결절로 진단하기 어려운 경우이다. 갑상선암 위험도가 5 ~ 15%이다. "4"는 "여포성 종양(또는 여포성 종양 의심)"이다. 갑상선암 위험도가 15 ~ 30%이다. "5"는 "갑상선암 의심"이다. 갑상선암 위험도는 60 ~ 75%이며 갑상선 수술이 권고된다. "6"은 "갑상선암"으로 진단된 경우이며, 갑상선암 위험도는 97 ~ 99%이다."1" means "non-diagnostic result", and the cell number is not enough to accurately diagnose. Typically, the risk of thyroid cancer is 1 to 4%, but retesting is needed. "2" is "benign nodule" and the risk of thyroid cancer is 0 to 3%. "3" is an undetermined nodule divided into "AUS" and "FLUS". Some cells are atypical, suspected of having thyroid cancer, or difficult to diagnose with clear benign nodules. Thyroid cancer risk is 5 to 15%. "4" is "follicular tumor (or suspected follicular tumor)". Thyroid cancer risk is 15 to 30%. "5" is "suspect thyroid cancer". Thyroid cancer risk is 60 to 75% and thyroid surgery is recommended. "6" is diagnosed as "thyroid cancer" and the thyroid cancer risk is 97 to 99%.
이러한 조직검사결과는 EMR 데이터베이스(220)에 구비된 별도의 조직검사기록 입력부(225)를 통하여 병원 데이터베이스(200)의 EMR 데이터베이스(220)에 업로드된다. The biopsy results are uploaded to the EMR database 220 of the hospital database 200 through a separate biopsy record input unit 225 provided in the EMR database 220.
물론, 이전에 조직검사가 이루어지지 않았던 환자는 이전 조직검사결과(Previous Biopsy Result)가 없음은 당연하다. Of course, patients who have not previously been biopsied have no previous biopsy results.
위험도 연산수단(310)은, 이와 같이 수집된 다수의 팩터의 값과 이전 조직검사결과(Previous Biopsy Result)를 종합하여 갑상선암의 위험도를 자동으로 연산한다. 구체적인 연산방법은 아래에서 상술한다.The risk calculating means 310 automatically calculates the risk of thyroid cancer by combining the values of the plurality of factors thus collected and previous biopsy results. A specific calculation method is described in detail below.
진단정보 연산수단(320)은, 위험도 연산수단(310)의 연산 결과를 토대로, "경과관찰" 또는 "조직검사" 중 어느 하나를 진단정보로서 연산하여 출력부(400)를 통해 출력한다. 한편, 진단정보 연산수단(320)은 하나의 기준을 더 활용하는데, 이는 일반적인 가이드라인 기준이다. 가이드라인 기준은 가이드라인 데이터베이스(500)에서 추출될 수 있다.The diagnostic information calculating means 320 calculates any one of "experimental observation" or "tissue examination" as diagnostic information based on the calculation result of the risk calculating means 310 and outputs it through the output unit 400. On the other hand, the diagnostic information calculation means 320 further utilizes one criterion, which is a general guideline criterion. Guidelines criteria may be extracted from the guidelines database 500.
가이드라인 데이터베이스(500)는 인터넷 웹사이트 중 갑상선암 여부를 결정하는 기준이 제공되는 웹사이트로서 미리 결정된 웹사이트에서 가이드라인에 대한 정보를 추출하여 가이드라인 기준으로 저장한 데이터베이스이다. The guideline database 500 is a website provided with a criterion for determining whether thyroid cancer is among Internet websites. The guideline database 500 extracts information about a guideline from a predetermined website and stores the guideline as a guideline.
상기 미리 결정된 웹사이트는, 예를 들어 대한갑상선영상의학회(http://thyroidimaging.kr/)일 수 있으며, 본 발명에 따른 시스템은 상기 웹사이트에 포함되어 있는 데이터 중 "기준"을 색인으로 설정하여 "갑상선 결절기준(KSThR guideline)"을 자동으로 추출할 수 있다. 추출된 갑상선 결절기준(KSThR guideline)은, 예를 들어 결절의 지름이 2cm, 1cm, 5mm를 기준으로 하는 양성 가능 결절, 불확정결절(indeterminate), 악성의심결절(suspicious malignant), 정상의 구분의 기준일 수 있으며, 여기에서 결절의 지름은 전술한 이미지 분석수단(120)에서 분석된 값 중 하나이므로 어디에 해당하는지 여부가 자동으로 결정된다. The predetermined website may be, for example, the Korean Society of Thyroid Imaging Medicine (http://thyroidimaging.kr/), and the system according to the present invention sets the index of "reference" among the data included in the website. The "KSThR guideline" can be extracted automatically. The extracted thyroid nodule (KSThR guideline) is, for example, the basis for the classification of benign nodules, indeterminate nodules, suspicious malignants, and normal nodules with nominal diameters of 2 cm, 1 cm, and 5 mm. In this case, since the diameter of the nodule is one of the values analyzed by the above-described image analyzing means 120, it is automatically determined where it corresponds.
전술한 대한갑상선영상의학회의 갑상선 결절기준(KSThR guideline)은 하나의 예시에 불과하며, 전술한 바와 같이 "기준"을 색인으로 설정하여 갑상선 결절기준을 추출할 수 있는 어떠한 웹사이트에도 적용 가능함은 물론이다. The above-mentioned thyroid nodule (KSThR guideline) of the Korean Society of Thyroid Imaging Medicine is just one example, and as described above, it can be applied to any website that can extract the thyroid nodule by setting the "reference" as an index. to be.
갑상선암 자동 판별 방법의 설명Description of automatic thyroid cancer detection method
이하, 도 3, 도 5를 참조하여 갑상선암 자동 판별 방법을 설명한다.Hereinafter, a method for automatically determining thyroid cancer will be described with reference to FIGS. 3 and 5.
종래기술과 유사하게 담당의가 환자를 진료하며 갑상선암이 의심되면 초음파 영상의 촬영을 권유하고, 환자는 초음파 기계(100)에서 초음파 촬영한다. 촬영한 초음파 이미지는 이미지 추출수단(110)에 의하여 추출된다(S100). Similarly to the prior art, the attending physician treats the patient and recommends taking an ultrasound image when the thyroid cancer is suspected, and the patient takes an ultrasound image in the ultrasound machine 100. The captured ultrasound image is extracted by the image extracting means 110 (S100).
여기에서, 초음파 이미지는 의사가 프로브를 이용하여 직접 환자의 초음파 촬영을 한 이미지일 수도 있으며, 또는 겔-패드형 프로브(gel-pad probe)를 이용하여 자동으로 스캔된 이미지일 수도 있다.Here, the ultrasound image may be an image in which a doctor directly takes an ultrasound image of a patient using a probe, or may be an image automatically scanned using a gel-pad probe.
다음, 본 발명 고유의 이미지 분석수단(120)은 추출된 초음파 이미지에서 결절들을 감지하고, 우선순위를 결정하며, 각각의 결절마다 다수의 팩터의 값을 연산한다(S200). 여기에서 연산되는 다수의 팩터는, 지름(Diameter), 내부성분(Internal Content), 해면상(Spongiform appearance), 형상(Shape), 경계(Margin), 에코도(Echogenicity), 및 석회화(Calcification)의 일곱 개이다. Next, the image analysis means 120 of the present invention detects the nodules in the extracted ultrasound image, determines the priority, and calculates values of a plurality of factors for each nodule (S200). Many of the factors computed here are seven: Diameter, Internal Content, Spongiform appearance, Shape, Margin, Echogenicity, and Calcification. Dog.
한편, 다른 실시예에서는 별도의 입력부(315)를 이용하여 위의 다수의 팩터의 값을 수동으로 입력할 수도 있다. Meanwhile, in another embodiment, the value of the plurality of factors may be manually input by using a separate input unit 315.
다음, 위험도 연산수단(310)이 상기 다수의 팩터의 값을 종합하여 미리 결정된 방식으로 위험도를 연산한다(S300). Next, the risk calculating unit 310 calculates the risk in a predetermined manner by combining the values of the plurality of factors (S300).
예를 들어, 일곱 개의 팩터들 각각 0 ~ 10점을 부여한 후(갑상선암 위험도가 높은 경우가 10점), 이들을 합산하는 방식을 사용할 수 있다. 또 다른 예를 들어, 지름의 팩터는 후술할 다른 기준으로도 사용되는바 제외할 수도 있다. 또 다른 예를 들어, 각각의 팩터들에 가중치를 부여할 수도 있다. 또 다른 예를 들어, 어느 하나의 팩터라도 10점에 가까워지는 경우 위험도를 높이는 방식으로 연산될 수도 있다. 이와 같이, 일곱 개의 팩터들이 자동 또는 수동으로 추출되면 이들을 어떠한 방식으로 조합하여도 무방하며, 본 발명에서 청구하고자 하는 범위는 이러한 다수의 팩터를 사용하여 갑상선암 여부를 판별하는 것이지 해당 팩터의 값을 연산하는 구체적 수식은 아님을 언급하여 둔다. For example, after assigning 0 to 10 points to each of the seven factors (10 points when the risk of thyroid cancer is high), a method of adding them up may be used. As another example, the diameter factor may be excluded as it is used as another criterion to be described later. As another example, each factor may be weighted. For another example, if any one factor approaches 10, it may be calculated in a manner that increases the risk. As such, if seven factors are automatically or manually extracted, they may be combined in any way, and the scope of the present invention is to determine whether thyroid cancer is used using a plurality of factors, and calculates the value of the factor. Note that it is not a specific formula to.
한편, 기존의 조직검사기록이 있는 경우에는 EMR 데이터베이스(220)에 저장된 진료기록, 즉 이전 조직검사결과(Previous Biopsy Result)를 더 이용한다. 이전 조직검사결과(Previous Biopsy Result)는 전술한 바와 같이 6단계 진단분류법(Bethesda System for Reporting Thyroid Cytopathology)으로 저장되어 있어서 각각의 값을 산출할 수 있는바, 전술한 일곱 개의 팩터에 이를 부가할 수 있다.On the other hand, when there is an existing biopsy record, the medical record stored in the EMR database 220, that is, the previous biopsy result (Previous Biopsy Result) is further used. Previous Biopsy Results are stored in a six-step diagnostic system (Bethesda System for Reporting Thyroid Cytopathology), as described above, to calculate each value, which can be added to the seven factors described above. have.
이와 같은 방식으로 본 발명에 따른 시스템에 의하여 위험도가 연산되면, 위험도가 기 설정된 범위 미만인지 여부를 토대로 다른 진단이 이루어진다. 도면에 도시된 바와 같이, 위험도가 5% 미만인 경우라면(S400) 지름이 2cm 이하인 경우에는(S500) 조직검사가 필요하지 않으며 "경과관찰"로서 진단할 수 있다. 즉, 출력부(400)를 통하여 "경과관찰"이 출력된다(S600). 지름이 2cm 초과인 경우에는 조직검사가 필요하기에, 출력부(400)를 통하여 "조직검사"가 출력된다(S700).When the risk is calculated by the system according to the invention in this way, another diagnosis is made based on whether the risk is below a preset range. As shown in the figure, if the risk is less than 5% (S400) if the diameter is 2cm or less (S500), a biopsy is not necessary and can be diagnosed as "overview". That is, "pass observation" is output through the output unit 400 (S600). If the diameter is more than 2cm, because a biopsy is necessary, the "history examination" is output through the output unit 400 (S700).
이와 같은 출력은 초음파 기계(100)에 구비된 모니터를 통하여 초음파 이미지와 함께 출력되거나, 병원 내의 PACS 또는 EMR과 연계된 모니터를 통하여 출력되거나, 그 방식에 제한이 없음은 물론이다.Such output is output along with the ultrasound image through the monitor provided in the ultrasound machine 100, through the monitor associated with the PACS or EMR in the hospital, or of course there is no limitation.
한편, 본 발명에 따른 시스템에 의하여 위험도가 5% 이상인 것으로 연산되었다면, 무조건적인 조직검사보다는 가이드라인 데이터베이스(500)로부터 불러온 가이드라인 기준을 한번 더 적용함이 바람직하다. 예를 들어, 가이드라인 기준이 전술한 대한갑상선영상의학회의 갑상선 결절기준(KSThR guideline)인 경우 해당 결절이 불확정결절(indeterminate)이라면(S410) 지름이 1cm 이하인 경우에는(S510) 조직검사가 필요하지 않으며 경과관찰로서 진단할 수 있다. 즉, 출력부(400)를 통하여 "경과관찰"이 출력된다(S600). 2cm에서 1cm로 낮추어진 것은 위험도가 높기에 보다 엄격한 기준을 적용한 것이다. 지름이 1cm 초과인 경우에는 조직검사가 필요하기에, 출력부(400)를 통하여 "조직검사"가 출력된다(S700).On the other hand, if the risk is calculated to be 5% or more by the system according to the present invention, it is preferable to apply the guidelines once again from the guidelines database 500 rather than unconditional biopsy. For example, if the guideline is the above-mentioned thyroid nodule (KSThR guideline) of the Korean Society of Thyroid Imaging Medicine (S410), if the nodule (indeterminate) (S410) If the diameter is less than 1cm (S510), a biopsy is not necessary. It can be diagnosed as follow-up observation. That is, "pass observation" is output through the output unit 400 (S600). Lowering from 2 cm to 1 cm is a higher risk and a stricter standard. If the diameter is more than 1 cm, since a biopsy is necessary, the "history examination" is output through the output unit 400 (S700).
여기에서, 불확정결절이 아니라면 지름이 0.5cm 이하인 경우에는(S520) 조직검사가 필요하지 않으며 경과관찰로서 진단할 수 있다. 즉, 출력부(400)를 통하여 "경과관찰"이 출력된다(S600). 1cm에서 0.5cm로 낮추어진 것은 불확정결절도 아니기에 위험도가 더 높아졌음을 반영한 것이다. 지름이 0.5cm 초과인 경우에는 조직검사가 필요하기에, 출력부(400)를 통하여 "조직검사"가 출력된다(S700).Here, if the diameter is not 0.5cm or less if the indeterminate nodule (S520) does not require a biopsy and can be diagnosed as a follow-up observation. That is, "pass observation" is output through the output unit 400 (S600). The decrease from 1 cm to 0.5 cm reflects a higher risk because it is not an indeterminate nodule. If the diameter is more than 0.5cm, because a biopsy is necessary, the "history examination" is output through the output unit 400 (S700).
이와 같은 절차를 통하여 조직검사가 이루어졌다면, 그 결과는 EMR 데이터베이스(220)에 다시 저장된다(S810). 저장되는 양식은 전술한 바와 같다.If the biopsy is performed through such a procedure, the result is stored in the EMR database 220 again (S810). The form to be stored is as described above.
또한, 초음파 기계(100)를 통하여 2차 초음파 검사를 하게 되며, 해당 초음파 이미지는 2차 초음파 이미지로서 이미지 추출수단에 의하여 추출되고(S820), 이미지 분석수단에 의하여 다수의 팩터의 각각의 값이 재연산된다(S830). 그 방법은 전술한 바와 같다. In addition, the second ultrasonic inspection is performed through the ultrasonic machine 100, and the corresponding ultrasonic image is extracted by the image extracting means as the second ultrasonic image (S820), and each value of the plurality of factors is determined by the image analyzing means. It is recalculated (S830). The method is as described above.
이제, 위험도 연산수단(310)은 재연산된 다수의 팩터의 값과, S720 단계에서 조직검사가 EMR 데이터베이스(220)에 업로드됨으로써 갱신된 진료기록을 종합하여 다시 한번 2차 위험도를 연산한다(S840). 연산 결과 여전히 2차 위험도가 5% 이상이라면(S850) 출력부(400)는 다시 "조직검사"를 출력하고(S860), 그렇지 않다면 여전히 "경과관찰"을 출력한다.Now, the risk calculating means 310 calculates the second risk once again by combining the values of the plurality of factors recomputed and the medical records updated by uploading the biopsy to the EMR database 220 in step S720 (S840). ). If the secondary risk is still 5% or more as a result of the calculation (S850), the output unit 400 outputs a "history examination" again (S860), and still outputs an "observation".
이와 같은 방법은 다음의 장점을 갖는다.This method has the following advantages.
종래 기술에서는 판독의의 주관적 관점에 크게 의존하지만, 본 발명은 총 일곱 개 이상의 팩터들을 토대로 객관적인 기준을 제시하여 보편성과 정확성을 크게 향상시킬 수 있다.While the prior art relies heavily on the subjective point of view of the reading, the present invention can improve the universality and accuracy by presenting an objective criterion based on a total of seven or more factors.
또한, 종래 기술에서는 판독의의 주관적 관점에 따라 판단된 1차 위험도만을 기준으로 경과관찰과 조직검사 여부를 결정하였다면(즉, 판단의의 주관적 관점이 기준이 되어 S400 단계에서 절차가 종료), 본 발명은 판단의의 주관적 관점은 배제하고 이전 조직검사결과(Previous Biopsy Result)가 활용되고, 가이드라인 기준이 활용되며, 2회 이상의 초음파 이미지 분석 결과가 더 활용되기에 정확도가 매우 높고, 불필요한 조직검사 내지 암 제거 수술을 권장하지 않게 된다.In addition, in the prior art, if it was determined whether the observation and histological examination were based on only the primary risk determined according to the subjective viewpoint of the reading (that is, the procedure is terminated at the step S400 based on the subjective viewpoint of the judgment). The invention excludes the subjective point of view of judgment and utilizes previous biopsy results, guideline criteria, and more than two times of ultrasound image analysis results. Or cancer removal surgery is not recommended.
또한, 모든 조직검사기록은 물론 모든 초음파 이미지에서 추출된 다수의 팩터의 값이 누적이 되는데, 최종적으로 암으로 진단되었는지 여부도 함께 기록된다. 이를 통하여 누적된 데이터들이 빅데이터를 형성하여 본 발명에 의한 판별 방법의 정확도가 점차 상승하게 된다. In addition, all histological records, as well as values of a number of factors extracted from all ultrasound images, are accumulated, and whether or not it is finally diagnosed as cancer. As a result, the accumulated data form big data, thereby increasing the accuracy of the discriminating method according to the present invention.
더욱이, 향후 가이드라인이 변경되거나 6단계 진단분류법(Bethesda System for Reporting Thyroid Cytopathology)이 변경된 경우에도 자동으로 해당 기준이 적용되어 최신의 기준이 활용될 수 있다. Moreover, even if the guidelines change in the future or the Six-stage System for Reporting Thyroid Cytopathology changes, the criteria are automatically applied so that the latest standards can be utilized.
상기에서는 본 발명의 바람직한 실시 예를 참조하여 설명하였지만, 당업계에서 통상의 지식을 가진 자라면 이하의 특허 청구범위에 기재된 본 발명의 사상 및 영역을 벗어나지 않는 범위 내에서 본 발명을 다양하게 수정 및 변경시킬 수 있음을 이해할 수 있을 것이다.Although described above with reference to a preferred embodiment of the present invention, those of ordinary skill in the art various modifications and variations of the present invention within the scope and spirit of the present invention described in the claims below It will be appreciated that it can be changed.

Claims (18)

  1. (a) 이미지 추출수단(110)이 초음파 이미지를 추출하는 단계; (a) the image extracting means 110 extracting the ultrasound image;
    (b) 이미지 분석수단(120)이 상기 추출된 초음파 이미지에서 결절을 감지하고 상기 결절의 다수의 팩터의 값을 연산하는 단계; (b) the image analyzing means 120 detecting a nodule in the extracted ultrasound image and calculating values of a plurality of factors of the nodule;
    (c) 위험도 연산수단(310)이 데이터베이스로부터 진료기록을 불러오고, 상기 (b) 단계의 다수의 팩터의 값과 상기 진료기록을 이용하여 미리 결정된 방법에 의해 위험도를 연산하는 단계;(c) the risk calculating means (310) retrieving medical records from a database, and calculating the risk by a predetermined method using the values of the plurality of factors and the medical records of step (b);
    (d) 상기 위험도 연산수단(310)이, 상기 연산된 위험도가 미리 결정된 기준 이상인 경우, 상기 감지된 결절이 가이드라인 기준에 따른 미리 결정된 형상의 결절인지 여부를 판단하는 단계; (d) determining, by the risk calculating means 310, whether the detected nodule is a nodule of a predetermined shape according to a guideline criterion when the calculated risk is greater than or equal to a predetermined criterion;
    (e) 상기 가이드라인 기준에 따른 미리 결정된 형상의 결절인 경우, 진단정보 연산수단(320)이 상기 결절의 지름이 1cm 초과인지 여부를 판단하는 단계; (e) in the case of a nodule of a predetermined shape according to the guidelines, the diagnostic information calculating means 320 determining whether the diameter of the nodule is greater than 1 cm;
    (f) 상기 진단정보 연산수단(320)이, 상기 결절의 지름이 1cm 초과인 경우 출력부(400)를 통하여 "조직검사"를 출력하고, 상기 결절의 지름이 1cm 이하인 경우 상기 출력부(400)를 통하여 "경과관찰"을 출력하는 단계를 포함하며, (f) the diagnostic information calculating means 320 outputs a "tissue examination" through the output unit 400 when the diameter of the nodule is greater than 1 cm, and outputs 400 when the diameter of the nodule is 1 cm or less. Outputting "observation" through),
    상기 (c) 단계의 진료기록은 이전 조직검사결과(Previous Biopsy Result)를 포함하는, The medical record of step (c) includes a previous biopsy result (Previous Biopsy Result),
    갑상선암 자동 판별 방법.Automated determination of thyroid cancer.
  2. 제 1 항에 있어서, The method of claim 1,
    상기 (d) 단계 이후, After the step (d),
    (d1) 상기 연산된 위험도가 상기 미리 결정된 기준 미만인 경우, 상기 진단정보 연산수단(320)이, 상기 결절의 지름이 2cm 초과인 경우 출력부(400)를 통하여 "조직검사"를 출력하고, 상기 결절의 지름이 2cm 이하인 경우 상기 출력부(400)를 통하여 "경과관찰"을 출력하는 단계를 더 포함하는, (d1) when the calculated risk is less than the predetermined criterion, the diagnostic information calculating means 320 outputs a "tissue examination" through the output unit 400 when the diameter of the nodule is greater than 2 cm, and the If the diameter of the nodules 2cm or less, further comprising the step of outputting "transspective observation" through the output unit 400,
    갑상선암 자동 판별 방법.Automated determination of thyroid cancer.
  3. 제 1 항에 있어서, The method of claim 1,
    상기 (d) 단계에서, 상기 미리 결정된 형상의 결절은 불확정결절인, In step (d), the nodule of the predetermined shape is an indeterminate nodule,
    갑상선암 자동 판별 방법.Automated determination of thyroid cancer.
  4. 제 1 항에 있어서, The method of claim 1,
    상기 (d) 단계 이후, After the step (d),
    (e1) 상기 가이드라인 기준에 따른 제 1 결절이 아닌 경우, 진단정보 연산수단(320)이 상기 결절의 지름이 0.5cm 초과인지 여부를 판단하는 단계; (e1) determining that the diameter of the nodule is greater than 0.5 cm by the diagnostic information calculating means (320) when it is not the first nodule according to the guidelines;
    (f1) 상기 진단정보 연산수단(320)이, 상기 결절의 지름이 0.5cm 초과인 경우 출력부(400)를 통하여 "조직검사"를 출력하고, 상기 결절의 지름이 0.5cm 이하인 경우 상기 출력부(400)를 통하여 "경과관찰"을 출력하는 단계를 더 포함하는, (f1) the diagnostic information calculating means 320 outputs a "tissue examination" through the output unit 400 when the diameter of the nodule is greater than 0.5 cm, and the output unit when the diameter of the nodule is 0.5 cm or less. And further outputting "observation" through 400;
    갑상선암 자동 판별 방법.Automated determination of thyroid cancer.
  5. 제 1 항에 있어서, The method of claim 1,
    상기 (f) 단계 이후, After the step (f),
    (g) 상기 데이터베이스에 조직검사 결과가 입력되어 진료기록이 갱신되는 단계; (g) inputting a biopsy result into the database to update a medical record;
    (h) 상기 이미지 추출수단(110)이 2차 초음파 이미지를 추출하는 단계; (h) extracting the second ultrasound image by the image extracting means (110);
    (i) 상기 이미지 분석수단(120)이 상기 추출된 2차 초음파 이미지에서 결절을 감지하고 상기 결절의 다수의 팩터의 값을 재연산하는 단계; (i) the image analyzing means (120) detecting a nodule in the extracted second ultrasound image and recalculating a value of a plurality of factors of the nodule;
    (j) 상기 위험도 연산수단(310)이 상기 (i) 단계에서 재연산된 다수의 팩터의 값과 상기 (g) 단계에서 갱신된 진료기록을 이용하여 상기 (c) 단계의 미리 결정된 방법에 의해 위험도를 연산하는 단계; (j) the risk calculating means 310 uses the values of the plurality of factors recalculated in the step (i) and the medical record updated in the step (g), by the predetermined method of the step (c). Calculating a risk;
    (k) 상기 연산된 위험도가 상기 미리 결정된 기준 이상인 경우 상기 진단정보 연산수단(320)은 상기 출력부(400)를 통하여 "조직검사"를 출력하고, 그렇지 않은 경우 상기 출력부(400)를 통하여 "경과관찰"을 출력하는 단계를 더 포함하는, (k) If the calculated risk is greater than or equal to the predetermined criterion, the diagnostic information calculating means 320 outputs a "tissue examination" through the output unit 400, otherwise, through the output unit 400. And further outputting "observation",
    갑상선암 자동 판별 방법.Automated determination of thyroid cancer.
  6. 제 5 항에 있어서, The method of claim 5, wherein
    상기 (c) 단계의 이전 조직검사결과(Previous Biopsy Result)와 상기 (g) 단계에서 입력되는 조직검사 결과는, 시술방법과 조직검사 결과로 구분된 것이며, The previous biopsy result of step (c) and the biopsy result input in step (g) are divided into the procedure and the biopsy result,
    상기 조직검사 결과는 6단계 진단분류법(Bethesda System for Reporting Thyroid Cytopathology)에 의한 값으로 기록된 결과인, The biopsy result is a result recorded as a value by a six-stage diagnostic classification method (Bethesda System for Reporting Thyroid Cytopathology),
    갑상선암 자동 판별 방법.Automated determination of thyroid cancer.
  7. 제 1 항 내지 제 6 항 중 어느 한 항에 있어서, The method according to any one of claims 1 to 6,
    상기 다수의 팩터는, 지름(Diameter), 내부성분(Internal Content), 해면상(Spongiform appearance), 형상(Shape), 경계(Margin), 에코도(Echogenicity), 및 석회화(Calcification)를 포함하는, The plurality of factors include diameter, internal content, sponge appearance, shape, margin, echogenicity, and calcification,
    갑상선암 자동 판별 방법.Automated determination of thyroid cancer.
  8. 제 7 항에 있어서, The method of claim 7, wherein
    상기 이미지 분석수단(120)은, 상기 (a) 단계에서 추출된 이미지를 이용하여, 상기 결절의 지름을 연산하고, 상기 결절의 내부성분을 고형성(solid), 거의 고형성(predominantly solid), 거의 낭성(predominantly cystic), 낭성(cystic) 중 어느 하나로 연산하고, 상기 결절의 해면상의 유무를 연산하고, 상기 결절의 형상을 타원형(ovoid/round), 비정형(irregular), 장방형(taller than wide, 앞뒤가 긴 모양)의 세 가지 중 어느 하나로 연산하고, 상기 결절의 경계를 부드러운 경계(smooth), 불규칙 경계(ill-defined), 침상경계(spiculated) 중 어느 하나로 연산하고, 상기 결절의 에코도를 분명한 저에코(marked hypoechogenicity), 저에코(hypoechogenicity), 등에코(isoechogenicity), 고에코(hyperechogenicity) 중 어느 하나로 연산하고, 상기 결절의 석회화를 미세석회화(microcalcification), 주변부석회화(rim calcification), 거대석회화(macrocalcification) 중 어느 하나로 연산하는, The image analyzing means 120 calculates the diameter of the nodule by using the image extracted in the step (a), and the internal components of the nodule are solid, almost solid, Calculate almost any cystic or cystic, calculate the presence or absence of spongy presence of the nodule, and shape the nodule in the shape of oval / round, irregular, or taler than wide. Compute the boundary of the nodule as one of smooth, ill-defined, and spiculated, and calculate the echogenicity of the nodule. Calculate any of the marked hypoechogenicity, hypoechogenicity, isoechogenicity, hyperechogenicity, and calculate the calcification of the nodule in microcalcification, rim calcification, large Operating with any one of calcification,
    갑상선암 자동 판별 방법.Automated determination of thyroid cancer.
  9. 제 7 항에 있어서, The method of claim 7, wherein
    상기 (b) 단계는, 입력부(315)가 상기 추출된 초음파 이미지에서 감지된 상기 결절의 다수의 팩터의 값을 입력하는 단계인, In the step (b), the input unit 315 is a step of inputting values of a plurality of factors of the nodule detected in the extracted ultrasound image.
    갑상선암 자동 판별 방법.Automated determination of thyroid cancer.
  10. 제 1 항에 있어서, The method of claim 1,
    상기 (b) 단계는, 상기 이미지 분석수단(120)은 상기 추출된 초음파 이미지에서 다수의 결절을 감지하고 상기 다수의 결절을 그 크기를 기준으로 우선순위를 설정하는 단계를 포함하는, In the step (b), the image analyzing means 120 includes detecting a plurality of nodules in the extracted ultrasound image and setting the priority of the plurality of nodules based on their size.
    갑상선암 자동 판별 방법.Automated determination of thyroid cancer.
  11. 초음파 이미지를 추출하는 이미지 추출수단(110); Image extracting means (110) for extracting an ultrasound image;
    상기 이미지 추출수단에서 추출된 초음파 이미지에서 결절을 감지하고 상기 결절의 다수의 팩터의 값을 연산하는 이미지 분석수단(120); Image analysis means (120) for detecting a nodule in the ultrasound image extracted by the image extraction means and calculating values of a plurality of factors of the nodule;
    데이터베이스로부터 진료기록을 불러오고, 상기 다수의 팩터의 값과 상기 진료기록을 이용하여 미리 결정된 방법에 의해 위험도를 연산하며, 상기 연산된 위험도가 미리 결정된 기준 이상인 경우, 상기 감지된 결절이 가이드라인 기준에 따른 미리 결정된 형상의 결절인지 여부를 판단하는, 위험도 연산수단(310);Retrieve a medical record from a database, calculate the risk by a predetermined method using the values of the plurality of factors and the medical record, and if the calculated risk is above a predetermined criterion, the detected nodule is based on guidelines. A risk calculating means 310 for determining whether a nodule of a predetermined shape according to;
    상기 가이드라인 기준에 따른 미리 결정된 형상의 결절인 경우 상기 결절의 지름이 1cm 초과인지 여부를 판단하는 진단정보 연산수단(320); 및Diagnostic information calculating means (320) for determining whether the diameter of the nodule is greater than 1 cm in the case of a nodule of a predetermined shape according to the guidelines; And
    상기 진단정보 연산수단(320)의 판단 결과, 상기 결절의 지름이 1cm 초과인 경우 "조직검사"가 출력되고 상기 결절의 지름이 1cm 이하인 경우 "경과관찰"을 출력되는 출력부(400)를 포함하며, As a result of the diagnosis information calculation means 320, the diameter of the nodule is more than 1cm "history examination" is output, and if the diameter of the nodules includes an output unit 400 for outputting "transspective observation" ,
    상기 진료기록은 이전 조직검사결과(Previous Biopsy Result)를 포함하는, The medical record includes a previous biopsy result,
    갑상선암 자동 판별 시스템.Thyroid cancer automatic identification system.
  12. 제 11 항에 있어서, The method of claim 11,
    상기 데이터베이스는 병원 데이터베이스(200)의 EMR(Electronic Medical Record) 데이터베이스(220)인, The database is an electronic medical record (EMR) database 220 of the hospital database 200,
    갑상선암 자동 판별 시스템.Thyroid cancer automatic identification system.
  13. 제 12 항에 있어서, The method of claim 12,
    상기 병원 데이터베이스(200)는, 상기 이미지 추출수단(100)에서 추출된 초음파 이미지와, 상기 이미지 분석수단(120)에서 연산된 다수의 팩터의 값이 업로드되는 PACS(Picture Archiving and Communication System) 데이터베이스(210)를 더 포함하는, The hospital database 200 may include a picture archiving and communication system (PACS) database in which ultrasound images extracted by the image extracting means 100 and values of a plurality of factors calculated by the image analyzing means 120 are uploaded. Further comprising 210),
    갑상선암 자동 판별 시스템.Thyroid cancer automatic identification system.
  14. 제 12 항에 있어서, The method of claim 12,
    상기 EMR 데이터베이스(220)에는 조직검사 결과가 더 입력될 수 있는, The EMR database 220 may be further input biopsy results,
    갑상선암 자동 판별 시스템.Thyroid cancer automatic identification system.
  15. 제 14 항에 있어서, The method of claim 14,
    상기 이전 조직검사결과(Previous Biopsy Result)와 상기 조직검사 결과는, 시술방법과 조직검사 결과로 구분된 것이며, 상기 조직검사 결과는 6단계 진단분류법(Bethesda System for Reporting Thyroid Cytopathology)에 의한 값으로 기록된 결과이며, The previous biopsy result (Previous Biopsy Result) and the biopsy results are divided into the procedure and the biopsy results, the biopsy results are recorded as a value by the six-step diagnostic system (Bethesda System for Reporting Thyroid Cytopathology) Result,
    상기 갑상선암 자동 판별 시스템은, 상기 이전 조직검사결과(Previous Biopsy Result)와 상기 조직검사 결과를 입력할 수 있는 조직검사기록 입력부(225)를 더 포함하는, The automatic thyroid cancer determination system further includes a biopsy record input unit 225 capable of inputting the previous biopsy result and the biopsy result.
    갑상선암 자동 판별 시스템.Thyroid cancer automatic identification system.
  16. 제 11 항에 있어서, The method of claim 11,
    상기 가이드라인 기준이 저장되는 가이드라인 데이터베이스(500)를 더 포함하는, Further comprising a guideline database 500 for storing the guideline criteria,
    갑상선암 자동 판별 시스템.Thyroid cancer automatic identification system.
  17. 제 16 항에 있어서, The method of claim 16,
    상기 가이드라인 데이터베이스(500)는, 미리 결정된 웹사이트에서 미리 결정된 방법에 따라 가이드라인에 대한 정보를 추출하여 상기 가이드라인 기준으로 저장한 것인, The guideline database 500 is to extract information about the guideline according to a predetermined method from a predetermined website and to store the guideline reference,
    갑상선암 자동 판별 시스템.Thyroid cancer automatic identification system.
  18. 제 11 항에 있어서, The method of claim 11,
    상기 다수의 팩터는 지름, 내부성분, 해면상, 형상, 경계, 에코도, 및 석회화를 포함하며, The plurality of factors include diameter, internal components, sea surface, shape, boundary, echo, and calcification,
    상기 갑상선암 자동 판별 시스템은, 상기 다수의 팩터의 값을 입력할 수 있는 입력부(315)를 더 포함하는, The automatic thyroid cancer determination system further includes an input unit 315 capable of inputting values of the plurality of factors.
    갑상선암 자동 판별 시스템.Thyroid cancer automatic identification system.
PCT/KR2015/012660 2014-11-25 2015-11-24 Method and system for automatic determination of thyroid cancer WO2016085236A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2014-0165481 2014-11-25
KR1020140165481A KR101656582B1 (en) 2014-11-25 2014-11-25 Method and system for detection of thyroid nodules

Publications (1)

Publication Number Publication Date
WO2016085236A1 true WO2016085236A1 (en) 2016-06-02

Family

ID=56074689

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2015/012660 WO2016085236A1 (en) 2014-11-25 2015-11-24 Method and system for automatic determination of thyroid cancer

Country Status (2)

Country Link
KR (1) KR101656582B1 (en)
WO (1) WO2016085236A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112102311A (en) * 2020-09-27 2020-12-18 平安科技(深圳)有限公司 Thyroid nodule image processing method and device and computer equipment
CN112184671A (en) * 2020-09-29 2021-01-05 平安科技(深圳)有限公司 Thyroid nodule aspect ratio calculation method, device, equipment and storage medium

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10993653B1 (en) 2018-07-13 2021-05-04 Johnson Thomas Machine learning based non-invasive diagnosis of thyroid disease
KR102485930B1 (en) * 2020-07-22 2023-01-10 연세대학교 산학협력단 Method for providing information of diagnosing gallbladder polyps and device for providing information diagnosing gallbladder polyps using the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100646828B1 (en) * 2005-10-08 2006-11-23 건국대학교 산학협력단 System for measurement mass size on breast mammogram and method therefor
JP2007524461A (en) * 2003-06-25 2007-08-30 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド Mammography automatic diagnosis and decision support system and method
JP2008520345A (en) * 2004-11-22 2008-06-19 ケアストリーム ヘルス インク Method and system for detecting and classifying lesions in ultrasound images
JP2009261608A (en) * 2008-04-24 2009-11-12 Konica Minolta Medical & Graphic Inc Ultrasonic tomographic imaging method and ultrasonic diagnostic apparatus
KR20140132839A (en) * 2013-05-07 2014-11-19 삼성전자주식회사 Ultrasonic imaging apparatus and image display method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007524461A (en) * 2003-06-25 2007-08-30 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド Mammography automatic diagnosis and decision support system and method
JP2008520345A (en) * 2004-11-22 2008-06-19 ケアストリーム ヘルス インク Method and system for detecting and classifying lesions in ultrasound images
KR100646828B1 (en) * 2005-10-08 2006-11-23 건국대학교 산학협력단 System for measurement mass size on breast mammogram and method therefor
JP2009261608A (en) * 2008-04-24 2009-11-12 Konica Minolta Medical & Graphic Inc Ultrasonic tomographic imaging method and ultrasonic diagnostic apparatus
KR20140132839A (en) * 2013-05-07 2014-11-19 삼성전자주식회사 Ultrasonic imaging apparatus and image display method thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112102311A (en) * 2020-09-27 2020-12-18 平安科技(深圳)有限公司 Thyroid nodule image processing method and device and computer equipment
CN112102311B (en) * 2020-09-27 2023-07-18 平安科技(深圳)有限公司 Thyroid nodule image processing method and device and computer equipment
CN112184671A (en) * 2020-09-29 2021-01-05 平安科技(深圳)有限公司 Thyroid nodule aspect ratio calculation method, device, equipment and storage medium
CN112184671B (en) * 2020-09-29 2023-12-19 平安科技(深圳)有限公司 Thyroid nodule aspect ratio calculation methods, apparatus, devices and storage medium

Also Published As

Publication number Publication date
KR20160062819A (en) 2016-06-03
KR101656582B1 (en) 2016-09-12

Similar Documents

Publication Publication Date Title
CN110600122B (en) Digestive tract image processing method and device and medical system
WO2018155898A1 (en) Method and apparatus for processing histological image captured by medical imaging device
WO2019172621A1 (en) Disease prediction method and disease prediction device using same
WO2019103440A1 (en) Method for supporting reading of medical image of subject and device using same
WO2017051944A1 (en) Method for increasing reading efficiency by using gaze information of user in medical image reading process and apparatus therefor
WO2016085236A1 (en) Method and system for automatic determination of thyroid cancer
US20140114679A1 (en) Method of anatomical tagging of findings in image data
WO2015041451A1 (en) Image diagnosis device for photographing breast by using matching of tactile image and near-infrared image and method for acquiring breast tissue image
US20080215525A1 (en) Medical image retrieval system
KR20200126303A (en) A artificial intelligence computer aided diagnosis system for automated analysis of cervical cancer cell image and its control method
WO2022014856A1 (en) Device and method for supporting chest medical image reading
CN109460717B (en) Digestive tract confocal laser microscopy endoscope lesion image identification method and device
US20140204242A1 (en) Exam review facilitated by clinical findings management with anatomical tagging
Hunt et al. Diagnosing cervical neoplasia in rural Brazil using a mobile van equipped with in vivo microscopy: A cluster-randomized community trial
Yang et al. An artificial intelligence system for distinguishing between gastrointestinal stromal tumors and leiomyomas using endoscopic ultrasonography
WO2016159726A1 (en) Device for automatically sensing lesion location from medical image and method therefor
WO2019098415A1 (en) Method for determining whether subject has developed cervical cancer, and device using same
CN112802000A (en) Intelligent auxiliary diagnosis and treatment system for multi-modal medical images
WO2021261808A1 (en) Method for displaying lesion reading result
WO2019143021A1 (en) Method for supporting viewing of images and apparatus using same
Li et al. The value of S-Detect for the differential diagnosis of breast masses on ultrasound: a systematic review and pooled meta-analysis
KR20230097646A (en) Artificial intelligence-based gastroscopy diagnosis supporting system and method to improve gastro polyp and cancer detection rate
US20230172425A1 (en) Information processing method, electronic device, and computer storage medium
CN102298666A (en) Vaginoscope network system and method for image quality estimation
WO2017010612A1 (en) System and method for predicting pathological diagnosis on basis of medical image analysis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15863430

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15863430

Country of ref document: EP

Kind code of ref document: A1